Pancras Hogendoorn
Hoogleraar Pathologie
- Naam
- Prof.dr. P.C.W. Hogendoorn
- Telefoon
- +31 71 526 2559
- p.c.w.hogendoorn@lumc.nl
- ORCID iD
- 0000-0002-1513-8104
Pancras C.W. Hogendoorn is hoogleraar pathologie, vicevoorzitter van de Raad van Bestuur en decaan van het Leids Universitair Medisch Centrum (LUMC). Daarnaast is hij gasthoogleraar bij de Universiteit van Oxford en de Vrije Universiteit Brussel. Hij is voorzitter van de Nederlandse Commissie voor Beentumoren, lid van de Raad van Toezicht van zorgorganisatie Pieter van Foreest en de Hogeschool der Kunsten Den Haag. Tevens is hij lid van de Koninklijke Nederlandse Academie van Wetenschappen (KNAW) en de Academia Europaea.
Meer informatie over Pancras Hogendoorn
Nieuws
Promovendi
-
Inge Hendriks, Nikolay Ivanovich Pirogov and his contribution to Medicine in 19th Century Imperial Russia
-
Paul Kemps, Langerhans cell histiocytosis
-
Pieter Valkema, Inflammation and Bone - insights from the abnormal inflammatory response in sternocostoclavicular hyperostosis
-
Maurits de Vries, Search for prognostic and therapeutic targets in Vestibular Schwannoma
Pancras C.W. Hogendoorn is hoogleraar pathologie, vicevoorzitter van de Raad van Bestuur en decaan van het Leids Universitair Medisch Centrum (LUMC). Daarnaast is hij gasthoogleraar bij de Universiteit van Oxford en de Vrije Universiteit Brussel. Hij is voorzitter van de Nederlandse Commissie voor Beentumoren, lid van de Raad van Toezicht van zorgorganisatie Pieter van Foreest en de Hogeschool der Kunsten Den Haag. Tevens is hij lid van de Koninklijke Nederlandse Academie van Wetenschappen (KNAW) en de Academia Europaea.
Pathologie
Pathologie is een verhelderend vak. Allerlei symptomen van ziekte - buikpijn, vergeetachtigheid, koorts - zijn terug te brengen naar veranderingen op celniveau. Naar het LUMC worden bijvoorbeeld veel patiënten met bot- en wekedelentumoren verwezen. Die melden zich eerst bij hun huisarts met pijn, vaak rond een gewricht. Na onder meer scans en bloedonderzoek ziet Hogendoorn de tumorcellen uiteindelijk onder de microscoop. Of soms zelfs nog kleiner, namelijk op DNA-niveau. Aan de manier waarop de cellen groeien en hoe ze eruitzien, bepaalt hij of het om een goedaardige of kwaadaardige tumor gaat. Dat is natuurlijk cruciaal voor de keuze van behandeling. Op grond van ziektesymptomen alleen is die zekerheid niet te geven. Misschien is dat wat hem nog het meest aan de microscoop en het laboratorium kluistert: de wens - de eis bijna - om iets zeker te weten. Zo min mogelijk onduidelijkheid en afleiding: dit zijn de feiten.
Wetenschappelijke carrière
Pancras C.W. Hogendoorn heeft zijn opleiding Geneeskunde en zijn promotieonderzoek gedaan aan de Universiteit van Leiden. De titel van zijn proefschrift (1990) luidt ‘Immunopathogenetic mechanisms in experimental glomerulonephritis’. Vervolgens specialiseerde Hogendoorn zich verder in de oncologische pathologie bij het Nederlands Kanker Instituut (NKI) in Amsterdam en het Memorial Sloan Kettering Cancer Center in New York. Hij werd in maart 1999 benoemd tot hoogleraar Pathologie van het Leids Universiteit Medisch Centrum. De titel van zijn oratie is ‘Form Follows Function’.
Al meer dan 30 jaar doet Hogendoorn onderzoek naar de moleculaire pathogenese en diagnostiek van bot- en wekedelentumoren. Hij heeft ruim 400 wetenschappelijke publicaties, diverse invloedrijke reviews en meer dan 30 boekhoofdstukken op zijn naam staan. Hij bekleedde een aantal nationale en internationale functies bij wetenschappelijke organisaties. Hij is thans voorzitter van de Nederlandse Commissie voor Beentumoren, lid kenniscoalitie voor de Nationale Wetenschapsagenda, CSO binnen het topteam Lifescience & Health (Health Holland), lid bestuurscommissie O&O bij de Nederlandse Federatie van Universitair Medische Centra en voorzitter van de LERU Policy Group in Biomedicine.
In het verleden was onder andere hij voorzitter van de subcommissie Pathologie en Biologie van de EORTC Soft tissue and Bone Sarcoma Group, European Osteosarcoma Intergroup, EuroEwing consortium, voorzitter van Eurolife en bestuurslid van de Connective Tissue Oncology Society and European Musculoskeletal Oncology Society, en voorzitter van de Bone and Soft Tissue working group van de European Society of Pathology.
Hogendoorn zat in de redactieraad van het prestigieuze tijdschrift Journal of Pathology. Hij deed hetzelfde werk voor Diagnostic Histopathology en Hereditary Cancer in Clinical Practice. Hogendoorn is nog steeds actief lid van de werkgroep bot- en wekedelentumoren van de European Society for Pathology. Vanwege zijn onderzoek en diagnostiek op het gebied van bot- en wekedelentumoren vroeg de Wereldgezondheidsorganisatie (WHO) hem in 2002 toe te treden tot de werkgroep voor classificatie van deze tumoren. In die functie schreef hij mee aan de WHO-classificatie voor bot- en wekedelentumoren en in 2013 werd hij benoemd tot editor van de meest recente editie.
Prijzen en eervolle benoemingen
Pancras C.W. Hogendoorn is erelid van de Belgium Society of Pathology. Hij ontving de European Oswald Vander Vekenprijs (2008), de Corrine Farrel Award in zowel 1994 als 1998 van de International Skeletal Society en de Jeremy Jass prize voor excellent onderzoek op het gebied van pathologie in 2011 en 2015. In 2019 ontving hij een doctorale honoris causa van Semmelweis Universiteit en werd hij verkozen tot lid van de Europese Academie voor Wetenschappen (Academia Europaea) en de Koninklijke Nederlandse Academie van Wetenschappen (KNAW).
Hoogleraar Pathologie
- Faculteit Geneeskunde
- Divisie 4
- Pathologie
Vicevoorzitter Raad van Bestuur en Decaan LUMC
- Faculteit Geneeskunde
- LUMC - Medische Faculteit Leiden
- Dorst, M.M.A.R. van; Pyuza, J.J.; Nkurunungi, G.; Kullaya, V.I.; Smits, H.H.; Hogendoorn, P.C.W.; Wammes, L.J.; Everts, B.; Elliott, A.M.; Jochems, S.P. & Yazdanbakhsh, M. (2023), Immunological factors linked to geographical variation in vaccine responses, Nature Reviews Immunology.
- Santoso, D.; Thaha, M.; Empitu, M.A.; Kadariswantiningsih, I.N.; Suryantoro, S.D.; Haryati, M.R.; Hertanto, D.M.; Pramudya, D.; Bintoro, S.U.Y.; Nasronudin, N.; Alsagaff, M.Y.; Susilo, H.; Wungu, C.D.K.; Budhiparama, N.C. & Hogendoorn, P.C.W. (2023), Brown tumour in chronic kidney disease: revisiting an old disease with a new perspective, Cancers 15(16).
- Venneker, S.; Eenige, R. van; Kruisselbrink, A.B.; Palubeckaite, I.; Taliento, A.E.; Briaire-de Bruijn, I.H.; Hogendoorn, P.C.W.; Sande, M.A.J. van de; Gelderblom, H.; Mei, H.L.; Bovee, J.V.M.G. & Szuhai, K. (2022), Histone deacetylase inhibitors as a therapeutic strategy to eliminate neoplastic "stromal" cells from giant cell tumors of bone, Cancers 14(19).
- Barnes, D.J.; Dutton, P.; Bruland, O.; Gelderblom, H.; Faleti, A.; Buhnemann, C.; Maldegem, A. van; Johnson, H.; Poulton, L.; Love, S.; Tiemeier, G.; Beelen, E. van; Herbschleb, K.; Haddon, C.; Billingham, L.; Bradley, K.; Ferrari, S.; Palmerini, E.; Picci, P.; Dirksen, U.; Strauss, S.J.; Hogendoorn, P.C.W.; Buddingh, E.; Blay, J.Y.; Cleton-Jansen, A.M. & Hassan, A.B. (2022), Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial), BMC Cancer 22(1).
- Khalil, R.; Boels, M.G.S.; Group, P.; Berg, B.M. van den; Bruijn, J.A.; Rabelink, T.J.; Hogendoorn, P.C.W. & Baelde, H.J. (2022), Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier, Molecular Genetics and Genomics 297.
- Kemps, P.G.; Picarsic, J.; Durham, B.H.; Helias-Rodzewicz, Z.; Hiemcke-Jiwa, L.; Bos, C. van den; Wetering, M.D. van de; Noesel, C.J.M. van; Laar, J.A.M. van; Verdijk, R.M.; Flucke, U.E.; Hogendoorn, P.C.W.; Woei-A-Jin, F.J.S.H.; Sciot, R.; Beilken, A.; Feuerhake, F.; Ebinger, M.; Mohle, R.; Fend, F.; Bornemann, A.; Wiegering, V.; Ernestus, K.; Mery, T.; Gryniewicz-Kwiatkowska, O.; Dembowska-Baginska, B.; Evseev, D.A.; Potapenko, V.; Baykov, V.V.; Gaspari, S.; Rossi, S.; Gessi, M.; Tamburrini, G.; Heritier, S.; Donadieu, J.; Bonneau-Lagacherie, J.; Lamaison, C.; Farnault, L.; Fraitag, S.; Jullie, M.L.; Haroche, J.; Collin, M.; Allotey, J.; Madni, M.; Turner, K.; Picton, S.; Barbaro, P.M.; Poulin, A.; Tam, I.S.; Demellawy, D. el; Empringham, B.; Whitlock, J.A.; Raghunathan, A.; Swanson, A.A.; Suchi, M.; Brandt, J.M.; Yaseen, N.R.; Weinstein, J.L.; Eldem, I.; Sisk, B.A.; Sridhar, V.; Atkinson, M.; Massoth, L.R.; Hornick, J.L.; Alexandrescu, S.; Yeo, K.K.; Petrova-Drus, K.; Peeke, S.Z.; Munoz-Arcos, L.S.; Leino, D.G.; Grier, D.D.; Lorsbach, R.; Roy, S.; Kumar, A.R.; Garg, S.; Tiwari, N.; Schafernak, K.T.; Henry, M.M.; Halteren, A.G.S. van; Abla, O.; Diamond, E.L. & Emile, J.F. (2022), ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition, Blood 139(2): 256-280.
- Yang, L.; Zhang, H.J.; Zhang, X.H.; Tang, Y.Q.; Wu, Z.G.; Wang, Y.M.; Huang, H.; Fu, X.; Liu, J.Y.; Hogendoorn, P.C.W. & Cheng, H. (2022), Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB), Annals of Diagnostic Pathology 57.
- Kemps, P.G.; Picarsic, J.; Durham, B.H.; Helias-Rodzewicz, Z.; Hiemcke-Jiwa, L.; Bos, C. van den; Wetering, M.D. van de; Noesel, C.J.M. van; Laar, J.A.M. van; Verdijk, R.M.; Flucke, U.E.; Hogendoorn, P.C.W.; Woei-A-Jin, F.J.S.H.; Sciot, R.; Beilken, A.; Feuerhake, F.; Ebinger, M.; Mohle, R.; Fend, F.; Bornemann, A.; Wiegering, V.; Ernestus, K.; Mery, T.; Gryniewicz-Kwiatkowska, O.; Dembowska-Baginska, B.; Evseev, D.A.; Potapenko, V.; Baykov, V.V.; Gaspari, S.; Rossi, S.; Gessi, M.; Tamburrini, G.; Heritier, S.; Donadieu, J.; Bonneau-Lagacherie, J.; Lamaison, C.; Farnault, L.; Fraitag, S.; Jullie, M.L.; Haroche, J.; Collin, M.; Allotey, J.; Madni, M.; Turner, K.; Picton, S.; Barbaro, P.M.; Poulin, A.; Tam, I.S.; Demellawy, D. el; Empringham, B.; Whitlock, J.A.; Raghunathan, A.; Swanson, A.A.; Suchi, M.; Brandt, J.M.; Yaseen, N.R.; Weinstein, J.L.; Eldem, I.; Sisk, B.A.; Sridhar, V.; Atkinson, M.; Massoth, L.R.; Hornick, J.L.; Alexandrescu, S.; Yeo, K.K.; Petrova-Drus, K.; Peeke, S.Z.; Munoz-Arcos, L.S.; Leino, D.G.; Grier, D.D.; Lorsbach, R.; Roy, S.; Kumar, A.R.; Garg, S.; Tiwari, N.; Schafernak, K.T.; Henry, M.M.; Halteren, A.G.S. van; Abla, O.; Diamond, E.L. & Emile, J.F. (2021), ALK-positive histiocytosis, Blood 139(2).
- Groen, R.A.L. de; Eijk, R. van; Bohringer, S.; Wezel, T. van; Raghoo, R.; Ruano, D.; Jansen, P.M.; Briaire-De Bruijn, I.; Groot, F.A. de; Kleiverda, K.; Boome, L. te; Terpstra, V.; Levenga, H.; Nicolae, A.; Posthuma, E.F.M.; Focke-Snieders, I.; Hardi, L.; Hartog, W.C.E. den; Bohmer, L.H.; Hogendoorn, P.C.W.; Berg, A. van den; Diepstra, A.; Nijland, M.; Lugtenburg, P.J.; Kersten, M.J.; Pals, S.T.; Veelken, H.; Bovee, J.V.M.G.; Cleven, A.H.G. & Vermaat, J.S.P. (2021), Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype, Blood Advances 5(19): 3760-3775.
- Forsyth, R.G.; Krenacs, T.; Athanasou, N. & Hogendoorn, P.C.W. (2021), Cell Biology of Giant Cell Tumour of Bone: Crosstalk between m/wt Nucleosome H3.3, Telomeres and Osteoclastogenesis, Cancers 13(20).
- Lam, S.W.; Bruijn, I.H.B.D.; Wezel, T. van; Cleven, A.H.G.; Hogendoorn, P.C.W.; Cleton-Jansen, A.M. & Bovee, J.V.M.G. (2021), NTRK fusions are extremely rare in bone tumours, Histopathology 79(5): 880-885.
- Yastrebinskii GB., State Museum Hermitage, St. Petersburg, Russian Federation Zhuravlev DA., Military Medical Museum, St. Petersburg, Russian Federation Gaivoronskii IV., S.M. Kirov Military Medical Academy, St. Petersburg & Russian Federation (2021), Medical instruments in Imperial Russia, Journal of Anatomy and Histopathology 10(2).
- Mremi, A.; Pyuza, J.J.; Ahmad, B.; Andongolile, A.A.; Sadiq, A.; Yahaya, J.J.; Szuhai, K. & Hogendoorn, P.C.W. (2021), Non-Hodgkin lymphoma of bone of the femur and humerus: a case report and review of the literature, Oxford Medical Case Reports: 150-152.
- Hosseini, R.; Lamers, G.E.M.; Bos, E.; Hogendoorn, P.C.W.; Koster, A.J.; Meijer, A.H.; Spaink, H.P. & Schaaf, M.J.M. (2021), The adapter protein Myd88 plays an important role in limiting mycobacterial growth in a zebrafish model for tuberculosis, Virchows Archiv 479.
- Hendriks, I.; Zhuravloyv, D.; Bovill, J.; Boer, F. & Hogendoorn, P. (2019), Women in healthcare in Imperial Russia, Journal of Medical Biography 29(1).
- Goriacheva, I.A., Military Medical Academy named S.M. Kirov, ul. Akademika Lebedeva 37, 194044 St.Petersburg, Russian Federation Gaivoronskii, I.V., Military Medical Academy named S.M. Kirov, ul. Akademika Lebedeva 37, 194044 St.Petersburg & Russian Federation (2020), The Dutchman Herman Boerhaave and the Russian Nikolay Ivanovich Pirogov are brilliant medical scientists, whose remembrance will be eternal., Vestnik Saint Petersburg University. Medicine. 15(2).
- Kravtsov, V.Y., Gaivoronskii, I.V., Academy named SM Kirov, St.Petersbrug & Russian Federation (2021), Dutch cultural heritage of Fredrik Ruijsch and Herman Boerhaave in the Military Medical Academy named SM Kirov., Vestnik Saint Petersburg University. Medicine. 16(14).
- Hernugrahanto, K.D.; Utomo, D.N.; Hariman, H.; Budhiparama, N.C.; Hertanto, D.M.; Santoso, D. & Hogendoorn, P.C.W. (2021), Thromboembolic involvement and its possible pathogenesis in COVID-19 mortality: lesson from post-mortem reports, European Review for Medical and Pharmacological Sciences 25(3): 1670-1679.
- D. A. Zhuravlev, Military Medical Museum, Lazeretniy pr. 2, St. Petersburg, 191180, Russian Federation. E. S. Houwaart, University of Maastricht, Peter Debyeplein 1, Postbus 616, 6200 MD Maastricht & the Netherlands. (2020), Nikolay Ivanovich Pirogov, Vestnik Saint Petersburg University. Medicine. 15(1).
- Wang, X.D.; Zhang, X.H.; Pan, W.L.; Han, Y.D.; Li, Y.W.; Sun, H.B.; Hogendoorn, P.C.W. & Cheng, H. (2020), Co-existence of lung carcinoma metastasis and enchondroma in the femur of a patient with Ollier disease, Virchows Archiv 479.
- Schutgens, E.M.; Picci, P.; Baumhoer, D.; Pollock, R.; Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Dijkstra, P.D.S.; Rueten-Budde, A.J.; Jutte, P.C.; Traub, F.; Leithner, A.; Tunn, P.U.; Funovics, P.; Sys, G.; San-Julian, M.; Schaap, G.R.; Durr, H.R.; Hardes, J.; Healey, J.; Capanna, R.; Biau, D.; Gomez-Brouchet, A.; Wunder, J.; Cosker, T.D.A.; Laitinen, M.K.; Niu, X.; Kostiuk, V.; Sande, M.A.J. van de & Adamantinoma Res Grp (2020), Surgical outcome and oncological survival of osteofibrous dysplasia-like and classic adamantinomas an international multicenter study of 318 cases, Journal of Bone and Joint Surgery 102(19): 1703-1713.
- Kemps, P.G.; Hebeda, K.M.; Pals, S.T.; Verdijk, R.M.; Lam, K.H.; Bruggink, A.H.; Lil, H.S. de; Ruiterkamp, B.; Heer, K. de; Laar, J.A.M. van; Valk, P.J.M.; Mutsaers, P.; Levin, M.D.; Hogendoorn, P.C.W. & Halteren, A.G.S. van (2021), Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation, Journal of Pathology: Clinical Research 7(1): 10-26.
- D. A. Zhuravlev, Military Medical Museum, St. Petersburg, Russian Federation. I. V. Gaivoronskii, Military Medical Academy named S.M. Kirov, St. Petersburg & Russian Federation (2020), Nikolay Ivanovich Pirogov as an innovator in anatomy, surgery, and anaesthesiology, Journal of Anatomy and Histopathology 9(3).
- Hendriks, I.F.; Zhuravlev, D.A.; Bovill, J.G.; Boer, F.; Gaivoronskii, I.V.; Hogendoorn, P.C.W. & DeRuiter, M.C. (2020), Nikolay Ivanovich Pirogov (1810-1881), Clinical Anatomy 33(5): 714-730.
- D. A. Zhuravlev, Military Medical Museum, St. Petersburg, Russian Federation. E. S. Houwaart, University of Maastricht, Maastricht, the Netherlands. I. V. Gaivoronskii, Military Medical Academy named S.M Kirov, St. Petersburg & Russian Federation (2020), Highlights of the professional activities of Nikolay Ivanovich Pirogov before and after his professoriate in Saint Petersburg (1841–1860). Part I, Journal of Anatomy and Histopathology 9(2).
- Venneker, S.; Szuhai, K.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2019), Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma, Virchows Archiv.
- D.A. Zhuravlev, Military Medical Museum, Lazeretniy 2, St.Petersburg, 191180, Russian Federation I.V. Gaivoronskii, Military Medical Academy S.M. Kirov, Ul. Akademika Lebedeva 6, St.Petersburg, 194044 & Russian Federation (2019), The development of Russian Medicine in the Petrine era and the role of Dutch doctors in this process., Vestnik Saint Petersburg University. Medicine. 14(2).
- Khalil, R.; Lalai, R.A.; Wiweger, M.I.; Avramut, C.M.; Koster, A.J.; Spaink, H.P.; Bruijn, J.A.; Hogendoorn, P.C.W. & Baelde, H.J. (2019), Glomerular permeability is not affected by heparan sulfate glycosaminoglycan deficiency in zebrafish embryos, American Journal of Physiology - Renal Physiology 317(5): F1211-F1216.
- Khalil, R.; Lalai, R.A.; Wiweger, M.I.; Avramut, C.M.; Koster, A.J.; Spaink, H.P.; Bruijn, J.A.; Hogendoorn, P.C.W. & Baelde, H.J. (2019), Glomerular permeability is not affected by heparan sulfate glycosaminoglycan deficiency in zebrafish embryos, American Journal of Physiology - Renal Physiology 317(5).
- Hendriks, I.F.; Zhuravlev, D.A.; Bovill, J.G.; Boer, F.; Gaivoronskii, I.V.; Hogendoorn, P.C.W. & DeRuiter, M.C. (2019), Nikolay Ivanovich Pirogov (1810–1881):Anatomical Research to Develop Surgery, Clinical Anatomy 00(0).
- Groot, V. de; Verhelst, E.; Hogendoorn, P.C.W. & Keizer, R.J.W. de (2019), Conjunctival Leiomyosarcoma, a Rare Neoplasm Always Originating at the Limbus? Report of a New Case and Review of 11 Published Cases, Ocular Oncology and Pathology 5(5): 333-339.
- Lipplaa, A.; Kroep, J.R.; Heijden, L. van der; Jutte, P.C.; Hogendoorn, P.C.W.; Dijkstra, S. & Gelderblom, H. (2019), Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial, Oncologist 24(7): 889-+.
- Orekhov, A.V. (2019), The role of Dutch representatives in the development of medicine in Russia from the 9th to the 13th century, Vestnik Saint Petersburg University. Medicine. 14(1).
- Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2019), Non-ossifying fibroma: A RAS-MAPK driven benign bone neoplasm, Journal of Pathology 248(2): 127-130.
- Lancia, C.; Anninga, J.K.; Sydes, M.R.; Spitoni, C.; Whelan, J.; Hogendoorn, P.C.W.; Gelderblom, H. & Fiocco, M. (2019), A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup, Cancer Chemotherapy and Pharmacology 83(5): 951-962.
- Lancia, C.; Anninga, J.; Spitoni, C.; Sydes, M.R.; Whelan, J.; Hogendoorn, P.C.W.; Gelderblom, H. & Fiocco, M. (2019), Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcoma, BMJ Open 9(5).
- Lipplaa, A.; Kroep, J.R.; Heijden, L. van der; Jutte, P.C.; Hogendoorn, P.C.W.; Dijkstra, S. & Gelderblom, H. (2019), Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial., The Oncologist 24(7).
- Vries, W.M. de; Briaire-de Bruijn, I.H.; Benthem, P.P.G. van; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2019), M-CSF and IL-34 expression as indicators for growth in sporadic vestibular schwannoma, Virchows Archiv 474(3): 375-381.
- Smeland, S.; Bielack, S.S.; Whelan, J.; Bernstein, M.; Hogendoorn, P.; Krailo, M.D.; Gorlick, R.; Janeway, K.A.; Ingleby, F.C.; Anninga, J.; Antal, I.; Arndt, C.; Brown, K.L.B.; Butterfass-Bahloul, T.; Calaminus, G.; Capra, M.; Dhooge, C.; Eriksson, M.; Flanagan, A.M.; Friedel, G.; Gebhardt, M.C.; Gelderblom, H.; Goldsby, R.; Grier, H.E.; Grimer, R.; Hawkins, D.S.; Hecker-Nolting, S.; Hall, K.S.; Isakoff, M.S.; Jovic, G.; Kuhne, T.; Kager, L.; Kalle, T. von; Kabickova, E.; Lang, S.; Lau, C.C.; Leavey, P.J.; Lessnick, S.L.; Mascarenhas, L.; Mayer-Steinacker, R.; Meyers, P.A.; Nagarajan, R.; Randall, R.L.; Reichardt, P.; Renard, M.; Rechnitzer, C.; Schwartz, C.L.; Strauss, S.; Teot, L.; Timmeimann, B.; Sydes, M.R. & Marina, N. (2019), Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort, European Journal of Cancer 109: 36-50.
- Khalil, R.; Koop, K.; Kreutz, R.; Spaink, H.P.; Hogendoorn, P.C.W.; Bruijn, J.A. & Baelde, H.J. (2019), Increased dynamin expression precedes proteinuria in glomerular disease, Journal of Pathology 247(2): 177-185.
- Edmunds, L.D.; Gluderer, S.; Ovseiko, P.V.; Kamerling, R.; Ton, J.; Vis, L.; Jenni, M.; Tutton, G.; Lawton-Smith, H.; Nadaban, M.V.; Rab, M.; Rees, J.; Anson, J.; Rushforth, A.D.; Allen, M.; Buchan, A.M.; Vendrell, M.; Casta, A.; Mehes, G.; Hogendoorn, P.C.W.; Hafen, E. & Hassan, A.B. (2019), New indicators and indexes for benchmarking university-industry-government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project, Health Research Policy and Systems 17.
- Calaminus, G.; Jenney, M.; Hjorth, L.; Baust, K.; Bernstein, M.; Bielack, S.; Vos, P. de; Hogendoorn, P.C.W.; Jovic, G.; Krailo, M.; Kreitz, K.; Marina, N.; Popoola, B.O.; Sauerland, C.; Smeland, S.; Teske, C.; Schweinitz, C.V.; Whelan, J.; Wiener, A.; Sydes, M.R. & Nagarajan, R. (2019), Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy, JMIR Research Protocols 8(9).
- Bosma, S.E.; Driel, P.B.A.A. van; Hogendoorn, P.C.W.; Dijkstra, P.D.S. & Sier, C.F.M. (2018), Introducing fluorescence guided surgery into orthopedic oncology: A systematic review of candidate protein targets for Ewing sarcoma, Journal of Surgical Oncology 118(6): 906-914.
- Wal, S. van der; Korne, C.M. de; Sand, L.G.L.; Willigen, D.M. van; Hogendoorn, P.C.W.; Szuhai, K.; Leeuwen, F.W.B. van & Buckle, T. (2018), Bioorthogonally Applicable Fluorescence Deactivation Strategy for Receptor Kinetics Study and Theranostic Pretargeting Approaches, ChemBioChem 19(16): 1758-1765.
- Verschoor, A.J.; Bovee, J.V.M.G.; Overbeek, L.I.H.; Hogendoorn, P.C.W.; Gelderblom, H. & PALGA Grp (2018), The incidence, mutational status, risk classification and referral pattern of gastro-intestinal stromal tumours in the Netherlands: a nationwide pathology registry (PALGA) study, Virchows Archiv 472(2): 221-229.
- Hendriks, I.F.; Bovill, J.G.; Luijt, P.A. van & Hogendoorn, P.C.W. (2018), Nikolay Ivanovich Pirogov (1810-1881): A pioneering Russian surgeon and medical scientist, Journal of Medical Biography 26(1): 10-22.
- Young, R.J.; Litiere, S.; Lia, M.; Hogendoorn, P.C.W.; Fisher, C.; Mechtersheimer, G.; Daugaard, S.; Sciot, R.; Collin, F.; Messiou, C.; Grunwald, V.; Gronchi, A.; Graaf, W. van der; Wardelmann, E. & Judson, I. (2017), Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study, Acta Oncologica 56(7): 1013-1020.
- Vries, M. de; Tellingen, O. van; Mey, A.G.L. van der; Bunt, A.M.G.; Briaire-de Bruijn, I. & Hogendoorn, P.C.W. (2017), BCRP expression in schwannoma, plexiform neurofibroma and MPNST, Oncotarget 8(51): 88751-88759.
- Sand, L.G.L.; Buckle, T.; Leeuwen, F.W.B. van; Corver, W.E.; Kruisselbrink, A.B.; Jochemsen, A.G.; Hogendoorn, P.C.W. & Szuhai, K. (2017), Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma, BMC Cancer 17.
- Casali, P.G.; Zalcberg, J.; Cesne, A. le; Reichardt, P.; Blay, J.Y.; Lindner, L.H.; Judson, I.R.; Schoffski, P.; Leyvraz, S.; Italiano, A.; Grunwald, V.; Pousa, A.L.; Kotasek, D.; Sleijfer, S.; Kerst, J.M.; Rutkowski, P.; Fumagalli, E.; Hogendoorn, P.; Litiere, S.; Marreaud, S.; Graaf, W. van der; Gronchi, A.; Verweij, J.; European Org Res Treatment Canc So; Italian Sarcoma Grp & Australasian Gastrointestinal Tria (2017), Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels, Journal of Clinical Oncology 35(15): 1713-+.
- Andritsch, E.; Beishon, M.; Bielack, S.; Bonvalot, S.; Casali, P.; Crul, M.; Delgado-Bolton, R.; Donatih, D.M.; Douis, H.; Haas, R.; Hogendoorn, P.; Kozhaeva, O.; Lavender, V.; Lovey, J.; Negrouk, A.; Pereira, P.; Roca, P.; Lempdes, G.R. de; Saarto, T.; Berck, B. van; Vassal, G.; Wartenberg, M.; Yared, W.; Costa, A. & Naredi, P. (2017), ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review, Critical Reviews in Oncology/Hematology 110: 94-105.
- Valkema, P.A.; Luymes, C.H.; Witteveen, J.E.; Cessie, S. le; Appelman-Dijkstra, N.M.; Hogendoorn, P.C.W. & Hamdy, N.A.T. (2017), High prevalence of autoimmune disease in the rare inflammatory bone disorder sternocostoclavicular hyperostosis: survey of a Dutch cohort, Orphanet Journal of Rare Diseases 12.
- Verdegaal, S.H.M.; Rijswijk, C.S. van; Brouwers, H.F.C.; Dijkstra, P.D.S.; Sand, M.A.J. van de; Hogendoorn, P.C.W. & Taminiau, A.H.M. (2016), MRI appearances of atypical cartilaginous tumour/grade I chondrosarcoma after treatment by curettage, phenolisation and allografting, Bone and Joint Journal 98B(12): 1674-1681.
- Marina, N.M.; Smeland, S.; Bielack, S.S.; Bernstein, M.; Jovic, G.; Krailo, M.D.; Hook, J.M.; Arndt, C.; Berg, H. van den; Brennan, B.; Brichard, B.; Brown, K.L.B.; Butterfass-Bahloul, T.; Calaminus, G.; Daldrup-Link, H.E.; Eriksson, M.; Gebhardt, M.C.; Gelderblom, H.; Gerss, J.; Goldsby, R.; Goorin, A.; Gorlick, R.; Grier, H.E.; Hale, J.P.; Hall, K.S.; Hardes, J.; Hawkins, D.S.; Helmke, K.; Hogendoorn, P.C.W.; Isakoff, M.S.; Janeway, K.A.; Jurgens, H.; Kager, L.; Kuhne, T.; Lau, C.C.; Leavey, P.J.; Lessnick, S.L.; Mascarenhas, L.; Meyers, P.A.; Mottl, H.; Nathrath, M.; Papai, Z.; Randall, R.L.; Reichardt, P.; Renard, M.; Safwat, A.A.; Schwartz, C.L.; Stevens, M.C.G.; Strauss, S.J.; Teot, L.; Werner, M.; Sydes, M.R. & Whelan, J.S. (2016), Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial, The Lancet Oncology 17(10): 1396-1408.
- Valkema, P.; Luymes, C.; Witteveen, J.; Cessie, S. le; Appelman-Dijkstra, N.; Hogendoorn, P. & Hamdy, N. (2016), High prevalence of autoimmune disease in the rare inflammatory bone disorder sternocostoclavicular hyperostosis, Virchows Archiv 469: S217-S217.
- Sand, L.G.L.; Berghuis, D.; Szuhai, K. & Hogendoorn, P.C.W. (2016), Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy, Cancer Immunology, Immunotherapy 65(8): 995-1002.
- Cleven, A.H.G.; Sannaa, G.A. al; Briaire-de Bruijn, I.; Ingram, D.R.; Rijn, M. van de; Rubin, B.P.; Vries, M.W. de; Watson, K.L.; Torres, K.E.; Wang, W.L.; Duinen, S.G. van; Hogendoorn, P.C.W.; Lazar, A.J. & Bovee, J.V.M.G. (2016), Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival, Modern Pathology 29(6): 582-590.
- Beletkaia, E.; Fenz, S.F.; Pomp, W.; Snaar-Jagalska, B.E.; Hogendoorn, P.W.C. & Schmidt, T. (2016), CXCR4 signaling is controlled by immobilization at the plasma membrane, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863(4): 607-616.
- Roos, E.; Coevorden, F. van; Verhoef, C.; Wouters, M.W.; Kroon, H.M.; Hogendoorn, P.C.W. & Houdt, W.J. van (2016), Prognosis of Primary and Recurrent Chondrosarcoma of the Rib, Annals of Surgical Oncology 23(3): 811-817.
- Maldegem, A.M. van; Bovee, J.V.M.G.; Peterse, E.F.P.; Hogendoorn, P.C.W. & Gelderblom, H. (2016), Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway, European Journal of Cancer 53: 171-180.
- Ent, W. van der; Veneman, W.J.; Groenewoud, A.; Chen, L.P.; Tulotta, C.; Hogendoorn, P.C.W.; Spaink, H.P.; Snaar-Jagalska, B.E. & Langenau, D.M. (2016), Automation of Technology for Cancer Research, Advances in Experimental Medicine and Biology 916: 315-332.
- Beletkaia E., Fenz S.A., Pomp W., Snaar-Jagalska B.E., Hogendoorn P.W.C. & Schmidt T. (2016), CXCR4 signaling is controlled by immobilization at the plasma membrane, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863(4): 607–616.
- Graaff, M.A. de; Jong, D. de; Briaire-De Bruijn, I.H.; Hogendoorn, P.C.W.; Bovee, J.V.M.G. & Szuhai, K. (2015), A translocation t(6;14) in two cases of leiomyosarcoma: Molecular cytogenetic and array-based comparative genomic hybridization characterization, Cancer Genetics 208(11): 537-544.
- Sand, L.G.L.; Scotlandi, K.; Berghuis, D.; Snaar-Jagalska, B.E.; Picci, P.; Schmidt, T.; Szuhai, K. & Hogendoorn, P.C.W. (2015), CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients, European Journal of Cancer 51(17): 2624-2633.
- Hoekstra, A.S.; Graaff, M.A. de; Briaire-de Bruijn, I.H.; Ras, C.; Seifar, R.M.; Minderhout, I. van; Cornelisse, C.J.; Hogendoorn, P.C.W.; Breuning, M.H.; Suijker, J.; Korpershoek, E.; Kunst, H.P.M.; Frizzell, N.; Devilee, P.; Bayley, J.P. & Bovee, J.V.M.G. (2015), Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors, Oncotarget 6(36): 38777-38788.
- Baranski, Z.; Jong, Y. de; Ilkova, T.; Peterse, E.F.P.; Cleton-Jansen, A.M.; Water, B. van de; Hogendoorn, P.C.W.; Bovee, J.V.M.G. & Danen, E.H.J. (2015), Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin, Oncotarget 6(34): 36113-36125.
- Cleven, A.H.G.; Zwartkruis, E.; Hogendoorn, P.C.W.; Kroon, H.M.; Briaire-de Bruijn, I. & Bovee, J.V.M.G. (2015), Periosteal chondrosarcoma: a histopathological and molecular analysis of a rare chondrosarcoma subtype, Histopathology 67(4): 483-490.
- Sand, L.G.L.; Jochemsen, A.G.; Beletkaia, E.; Schmidt, T.; Hogendoorn, P.C.W. & Szuhai, K. (2015), Novel splice variants of CXCR4 identified by transcriptome sequencing, Biochemical and Biophysical Research Communications 466(1): 89-94.
- Vries, M. de; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2015), Tumor Biology of Vestibular Schwannoma: A Review of Experimental Data on the Determinants of Tumor Genesis and Growth Characteristics, Otology and Neurotology 36(7): 1128-1136.
- Baranski, Z.; Booij, T.H.; Cleton-Jansen, A.M.; Price, L.S.; Water, B. van de; Bovee, J.V.M.G.; Hogendoorn, P.C.W. & Danen, E.H.J. (2015), Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma, Journal of Pathology 236(3): 348-359.
- Bielack, S.S.; Smeland, S.; Whelan, J.S.; Marina, N.; Jovic, G.; Hook, J.M.; Krailo, M.D.; Gebhardt, M.; Papai, Z.; Meyer, J.; Nadel, H.; Randall, R.L.; Deffenbaugh, C.; Nagarajan, R.; Brennan, B.; Letson, G.D.; Teot, L.A.; Goorin, A.; Baumhoer, D.; Kager, L.; Werner, M.; Lau, C.C.; Hall, K.S.; Gelderblom, H.; Meyers, P.; Gorlick, R.; Windhager, R.; Helmke, K.; Eriksson, M.; Hoogerbrugge, P.M.; Schomberg, P.; Tunn, P.U.; Kuhne, T.; Jurgens, H.; Berg, H. van den; Bohling, T.; Picton, S.; Renard, M.; Reichardt, P.; Gerss, J.; Butterfass-Bahloul, T.; Morris, C.; Hogendoorn, P.C.W.; Seddon, B.; Calaminus, G.; Michelagnoli, M.; Dhooge, C.; Sydes, M.R.; Bernstein, M. & EURAMOS-1 Investigators (2015), Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial, Journal of Clinical Oncology 33(20): 2279-U92.
- Heijden, L. van der; Sande, M.A.J. van de; Hogendoorn, P.C.W.; Gelderblom, H. & Dijkstra, P.D.S. (2015), Neoadjuvant denosumab for extensive giant cell tumor in os ischium - a case report, Acta Orthopaedica 86(3): 393-395.
- Whelan, J.S.; Bielack, S.S.; Marina, N.; Smeland, S.; Jovic, G.; Hook, J.M.; Krailo, M.; Anninga, J.; Butterfass-Bahloul, T.; Bohling, T.; Calaminus, G.; Capra, M.; Deffenbaugh, C.; Dhooge, C.; Eriksson, M.; Flanagan, A.M.; Gelderblom, H.; Goorin, A.; Gorlick, R.; Gosheger, G.; Grimer, R.J.; Hall, K.S.; Helmke, K.; Hogendoorn, P.C.W.; Jundt, G.; Kager, L.; Kuehne, T.; Lau, C.C.; Letson, G.D.; Meyer, J.; Meyers, P.A.; Morris, C.; Mottl, H.; Nadel, H.; Nagarajan, R.; Randall, R.L.; Schomberg, P.; Schwarz, R.; Teot, L.A.; Sydes, M.R.; Bernstein, M. & EURAMOS Collaborators (2015), EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment, Annals of Oncology 26(2): 407-414.
- Hendriks, I.F.; Bovill, J.G.; Boer, F.; Houwaart, E.S. & Hogendoorn, P.C.W. (2015), Nikolay Ivanovich Pirogov: a surgeon's contribution to military and civilian anaesthesia, Anaesthesia 70(2): 219-227.
- Houwaart, ES, Professor of Medical History, Department of Health, Ethics and Society, University of Maastricht, Maastricht & The Netherlands. (2015), Nikolay Ivanovich Pirogov: a surgeon’s contribution to military and civilian anaesthesia., Anaesthesia 70(2).
- Balluff, B.; Frese, C.K.; Maier, S.K.; Schone, C.; Kuster, B.; Schmitt, M.; Aubele, M.; Hofler, H.; Deelder, A.M.; Heck, A.J.R.; Hogendoorn, P.C.W.; Morreau, J.; Altelaar, A.F.M.; Walch, A. & McDonnell, L.A. (2015), De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry, Journal of Pathology 235(1): 3-13.
- Buddingh, E.P.; Ruslan, S.E.N.; Reijnders, C.M.A.; Szuhai, K.; Kuijjer, M.L.; Roelofs, H.; Hogendoorn, P.C.W.; Egeler, R.M.; Cleton-Jansen, A.M. & Lankester, A.C. (2015), Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture, Clinical Sarcoma Research 5.
- Sand, L.G.L.; Szuhai, K. & Hogendoorn, P.C.W. (2015), Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes, International Journal of Molecular Sciences 16(7): 16176.
- Vries, M. de; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2015), Tumor Biology of Vestibular Schwannoma: A Review of Experimental Data on the Determinants of Tumor Genesis and Growth Characteristics, Otology and Neurotology.
- Cesne, A. le; Ouali, M.; Leahy, M.G.; Santoro, A.; Hoekstra, H.J.; Hohenberger, P.; Coevorden, F. van; Rutkowski, P.; Hoesel, R. van; Verweij, J.; Bonvalot, S.; Steward, W.P.; Gronchi, A.; Hogendoorn, P.C.W.; Litiere, S.; Marreaud, S.; Blay, J.Y. & Graaf, W.T.A. van der (2014), Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials, Annals of Oncology 25(12): 2425-2432.
- Lieveld, M.; Bodson, E.; Boeck, G. de; Nouman, B.; Cleton-Jansen, A.M.; Korsching, E.; Benassi, M.S.; Picci, P.; Sys, G.; Poffyn, B.; Athanasou, N.A.; Hogendoorn, P.C.W. & Forsyth, R.G. (2014), Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis, Virchows Archiv 465(6): 703-713.
- Mohseny, A.B.; Hogendoorn, P.C.W. & Kleinerman, E.S. (2014), Zebrafish as a Model for Human Osteosarcoma, Advances in Experimental Medicine and Biology 804: 221-236.
- Heijden, L. van der; Dijkstra, P.D.S.; Sande, M.A.J. van de; Kroep, J.R.; Nout, R.A.; Rijswijk, C.S.P. van; Bovee, J.V.M.G.; Hogendoorn, P.C.W. & Gelderblom, H. (2014), Giant Cell Tumor of Bone Reply, The Oncologist 19(11): 1208-1208.
- Buhnemann, C.; Li, S.; Yu, H.Y.; White, H.B.; Schafer, K.L.; Llombart-Bosch, A.; Machado, I.; Picci, P.; Hogendoorn, P.C.W.; Athanasou, N.A.; Noble, J.A. & Hassan, A.B. (2014), Quantification of the Heterogeneity of Prognostic Cellular Biomarkers in Ewing Sarcoma Using Automated Image and Random Survival Forest Analysis, PLoS ONE 9(9).
- Ent, W. van der; Jochemsen, A.G.; Teunisse, A.F.A.S.; Krens, S.F.G.; Szuhai, K.; Spaink, H.P.; Hogendoorn, P.C.W. & Snaar-Jagalska, B.E. (2014), Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53, Journal of Pathology 233(4): 415-424.
- Pappo, A.S.; Vassal, G.; Crowley, J.J.; Bolejack, V.; Hogendoorn, P.C.W.; Chugh, R.; Ladanyi, M.; Grippo, J.F.; Dall, G.; Staddon, A.P.; Chawla, S.P.; Maki, R.G.; Araujo, D.M.; Geoerger, B.; Ganjoo, K.; Marina, N.; Blay, J.Y.; Schuetze, S.M.; Chow, W.A. & Helman, L.J. (2014), A Phase 2 Trial of R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients With Recurrent or Refractory Rhabdomyosarcoma, Osteosarcoma, Synovial Sarcoma, and Other Soft Tissue Sarcomas Results of a Sarcoma Alliance for Research Through Collaboration Study, Cancer 120(16): 2448-2456.
- Eckel, R.H.; Jakicic, J.M.; Ard, J.D.; Jesus, J.M. de; Miller, N.H.; Hubbard, V.S.; Lee, I.M.; Lichtenstein, A.H.; Loria, C.M.; Millen, B.E.; Nonas, C.A.; Sacks, F.M.; Smith, S.C.; Svetkey, L.P.; Wadden, T.A. & Yanovski, S.Z. (2014), 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Journal of the American College of Cardiology 63(25): 2960-2984.
- Nord, K.H.; Lilljebjorn, H.; Vezzi, F.; Nilsson, J.; Magnusson, L.; Tayebwa, J.; Jong, D. de; Bovee, J.V.M.G.; Hogendoorn, P.C.W. & Szuhai, K. (2014), GRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma, Nature Genetics 46(5): 474-477.
- Heijden, L. van der; Dijkstra, P.D.S.; Sande, M.A.J. van de; Kroep, J.R.; Nout, R.A.; Rijswijk, C.S.P. van; Bovee, J.V.M.G.; Hogendoorn, P.C.W. & Gelderblom, H. (2014), The Clinical Approach Toward Giant Cell Tumor of Bone, The Oncologist 19(5): 550-561.
- Kajtar, B.; Tornoczky, T.; Kalman, E.; Kuzsner, J.; Hogendoorn, P.C.W. & Szuhai, K. (2014), CD99-positive undifferentiated round cell sarcoma diagnosed on fine needle aspiration cytology, later found to harbour a CIC-DUX4 translocation: a recently described entity, Cytopathology 25(2): 129-132.
- Judson, I.; Verweij, J.; Gelderblom, H.; Hartmann, J.T.; Schoffski, P.; Blay, J.Y.; Kerst, J.M.; Sufliarsky, J.; Whelan, J.; Hohenberger, P.; Krarup-Hansen, A.; Alcindor, T.; Marreaud, S.; Litiere, S.; Hermans, C.; Fisher, C.; Hogendoorn, P.C.W.; Tos, A.P. dei; Graaf, W.T.A. van der; European Org & Treatment Canc Soft Tissue Bone Sa (2014), Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial, The Lancet Oncology 15(4): 415-423.
- Duijsens, H.M.; Vanhoenacker, F.M.; Braak, B.P. ter; Hogendoorn, P.C. & Kroon, H.M. (2014), PRIMARY INTRAOSSEOUS MANIFESTATION OF ROSAI-DORFMAN DISEASE: 2 CASES AND REVIEW OF LITERATURE, Jbr-btr 97(2): 84-89.
- Wiweger, M.I.; Andrea, C.E. de; Scheepstra, K.W.F.; Zhao, Z. & Hogendoorn, P.C.W. (2014), Possible effects of EXT2 on mesenchymal differentiation - lessons from the zebrafish, Orphanet Journal of Rare Diseases 9.
- Rajnai, H.; Heyning, F.H.; Koens, L.; Sebestyen, A.; Andrikovics, H.; Hogendoorn, P.C.W.; Matolcsy, A. & Szepesi, A. (2014), The density of CD8+T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone, Virchows Archiv 464(2): 229-239.
- Szuhai, K.; Jong, D. de; Leung, W.Y.; Fletcher, C.D.M. & Hogendoorn, P.C.W. (2014), Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma, Journal of Pathology 232(3): 300-307.
- Gelderblom, H.; Blay, J.Y.; Seddon, B.M.; Leahy, M.; Ray-Coquard, I.; Sleijfer, S.; Kerst, J.M.; Rutkowski, P.; Bauer, S.; Ouali, M.; Marreaud, S.; Straaten, R.J.H.M. van der; Guchelaar, H.J.; Weitman, S.D.; Hogendoorn, P.C.W. & Hohenberger, P. (2014), Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study, European Journal of Cancer 50(2): 388-396.
- Beletkaia, E.; Fenz, S.; Snaar-Jagalska, E.; Hogendoorn, P. & Schmidt, T. (2014), The Molecular Mechanisms of Gradient Sensing by CXCR4, Biophysical Journal 106(2): 519A-519A.
- Kuijjer, M.L.; Akker, B.E.W.M. van den; Hilhorst, R.; Mommersteeg, M.; Buddingh, E.P.; Serra, M.; Burger, H.; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2014), Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy, BMC Medical Genomics 7.
- Ent W. van der, Jochemsen A.G., Teunisse A.F., Krens S.G., Szuhai K., Spaink H.P., Hogendoorn P.C. & Snaar-Jagalska B.E. (2014), Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53, Journal of Pathology 223(4): 415-424.
- Solomon, D.A.; Kim, J.S.; Bondaruk, J.; Shariat, S.F.; Wang, Z.F.; Elkahloun, A.G.; Ozawa, T.; Gerard, J.; Zhuang, D.Z.; Zhang, S.Z.; Navai, N.; Siefker-Radtke, A.; Phillips, J.J.; Robinson, B.D.; Rubin, M.A.; Volkmer, B.; Hautmann, R.; Kufer, R.; Hogendoorn, P.C.W.; Netto, G.; Theodorescu, D.; James, C.D.; Czerniak, B.; Miettinen, M. & Waldman, T. (2013), Frequent truncating mutations of STAG2 in bladder cancer, Nature Genetics 45(12): 1428-U171.
- Kuijjer, M.L.; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2013), Genome-wide analyses on high-grade osteosarcoma: Making sense of a genomically most unstable tumor, International Journal of Cancer 133(11): 2512-2521.
- Nord, K.H.; Nilsson, J.; Arbajian, E.; Steyern, F.V. von; Brosjo, O.; Cleton-Jansen, A.M.; Szuhai, K. & Hogendoorn, P.C.W. (2013), Recurrent Chromosome 22 Deletions in Osteoblastoma Affect Inhibitors of the Wnt/Beta-Catenin Signaling Pathway, PLoS ONE 8(11).
- Keus, R.B.; Nout, R.A.; Blay, J.Y.; Jong, J.M. de; Hennig, I.; Saran, F.; Hartmann, J.T.; Sunyach, M.P.; Gwyther, S.J.; Ouali, M.; Kirkpatrick, A.; Poortmans, P.M.; Hogendoorn, P.C.W. & Graaf, W.T.A. van der (2013), Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis-an EORTC STBSG and ROG study (EORTC 62991-22998), Annals of Oncology 24(10): 2672-2676.
- Gautier, T.; Haan, W. de; Grober, J.; Ye, D.; Bahr, M.J.; Claudel, T.; Nijstad, N.; Berkel, T.J.C. van; Havekes, L.M.; Manns, M.P.; Willems, S.M.; Hogendoorn, P.C.W.; Lagrost, L.; Kuipers, F.; Eck, M. van; Rensen, P.C.N. & Tietge, U.J.F. (2013), Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice, Journal of Lipid Research 54(8): 2195-2205.
- Bielack, S.S.; Smeland, S.; Whelan, J.; Marina, N.; Hook, J.; Jovic, G.; Krailo, M.D.; Butterfass-Bahloul, T.; Kuhne, T.; Eriksson, M.; Teot, L.A.; Gelderblom, H.; Kager, L.; Hall, K.S.; Gorlick, R.G.; Randall, R.L.; Hogendoorn, P.C.W.; Calaminus, G.; Sydes, M.R. & Bernstein, M.L. (2013), MAP plus maintenance pegylated interferon alpha-2b (MAPIfn) versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 "good response" randomization., Journal of Clinical Oncology 31(18).
- Kuijjer, M.L.; Peterse, E.F.P.; Akker, B.E.W.M. van den; Briaire-de Bruijn, I.H.; Serra, M.; Meza-Zepeda, L.A.; Myklebost, O.; Hassan, A.B.; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2013), IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma, BMC Cancer 13.
- Bielack, S.S.; Smeland, S.; Whelan, J.; Marina, N.; Hook, J.; Jovic, G.; Krailo, M.D.; Butterfass-Bahloul, T.; Kuhne, T.; Eriksson, M.; Teot, L.A.; Gelderblom, H.; Kager, L.; Hall, K.S.; Gorlick, R.G.; Randall, R.L.; Hogendoorn, P.C.W.; Calaminus, G.; Sydes, M.R. & Bernstein, M.L. (2013), MAP plus maintenance pegylated interferon alpha-2b (MAP-IFN) versus MAP alone in patients (pts) with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomization., Journal of Clinical Oncology 31(15).
- Jones, E.A.; Schmitz, N.; Waaijer, C.J.F.; Frese, C.K.; Remoortere, A. van; Zeijl, R.J.M. van; Heck, A.J.R.; Hogendoorn, P.C.W.; Deelder, A.M.; Altelaar, A.F.M.; Bovee, J.V.M.G. & McDonnell, L.A. (2013), Imaging Mass Spectrometry-based Molecular Histology Differentiates Microscopically Identical and Heterogeneous Tumors, Journal of Proteome Research 12(4): 1847-1855.
- Oosterwijk, J.G. van; Meijer, D.; Ruler, M.A.J.H. van; Akker, B.E.W.M. van den; Oosting, J.; Krenacs, T.; Picci, P.; Flanagan, A.M.; Liegl-Atzwanger, B.; Leithner, A.; Athanasou, N.; Daugaard, S.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2013), Screening for Potential Targets for Therapy in Mesenchymal, Clear Cell, and Dedifferentiated Chondrosarcoma Reveals Bcl-2 Family Members and TGF beta as Potential Targets, American Journal of Pathology 182(4): 1347-1356.
- Heijden, L. van der; Gibbons, C.L.M.H.; Hassan, A.B.; Kroep, J.R.; Gelderblom, H.; Rijswijk, C.S.P. van; Nout, R.A.; Bradley, K.M.; Athanasou, N.A.; Dijkstra, P.D.S.; Hogendoorn, P.C.W. & Sande, M.A.J. van de (2013), A multidisciplinary approach to giant cell tumors of tendon sheath and synoviumA critical appraisal of literature and treatment proposal, Journal of Surgical Oncology 107(4): 433-445.
- Koens, L.; Heyning, F.H.; Szepesi, A.; Matolcsy, A.; Hogendoorn, P.C.W. & Jansen, P.M. (2013), Nuclear factor-kappa B activation in primary lymphoma of bone, Virchows Archiv 462(3): 349-354.
- Vries, M. de; Briaire-de Bruijn, I.; Cleton-Jansen, A.M.; Malessy, M.J.A.; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2013), Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomas, Virchows Archiv 462(2): 211-217.
- Solomon, D.A.; Bondaruk, J.; Shariat, S.F.; Wang, Z.F.; Elkahloun, A.G.; Zhang, S.; Navai, N.; Gerard, J.; Robinson, B.D.; Zhoung, D.; Rink, M.; Volkmer, B.; Hautmann, R.; Kufer, R.; Hogendoorn, P.C.W.; Netto, G.; Theodorescu, D.; Kim, J.S.; Czerniak, B.; Miettinen, M. & Waldman, T. (2013), Truncating Mutations of STAG2 Define a Molecular Subgroup of Aneuploid Bladder Cancers with Poor Prognosis.
- Anninga J.K., Picci P., Fiocco M., Kroon H.M.J.A., Vanel D., Alberghini M., Gelderblom H. & Hogendoorn P.C.W. (2013), Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup, Virchows Archiv 462(1): 109-120.
- Kacker, C.; Marx, A.; Mossinger, K.; Svehla, F.; Schneider, U.; Hogendoorn, P.C.W.; Nielsen, O.S.; Kuffer, S.; Sauer, C.; Fisher, C.; Hallermann, C.; Hartmann, J.T.; Blay, J.Y.; Mechtersheimer, G.; Hohenberger, P. & Strobel, P. (2013), High frequency of MYC gene amplification is a common feature of radiation-induced sarcomas. Further results from EORTC STBSG TL 01/01, Genes, Chromosomes and Cancer 52(1): 93-98.
- Pelczar, P.; Zibat, A.; Dop, W.A. van; Heijmans, J.; Bleckmann, A.; Gruber, W.; Nitzki, F.; Uhmann, A.; Guijarro, M.V.; Hernando, E.; Dittmann, K.; Wienands, J.; Dressel, R.; Wojnowski, L.; Binder, C.; Taguchi, T.; Beissbarth, T.; Hogendoorn, P.C.W.; Antonescu, C.R.; Rubin, B.P.; Schulz-Schaeffer, W.; Aberger, F.; Brink, G.R. van den & Hahn, H. (2013), Inactivation of Patched1 in Mice Leads to Development of Gastrointestinal Stromal-Like Tumors That Express Pdgfr alpha but Not Kit, Gastroenterology 144(1): 134-U256.
- Beletkaia, E.; Fenz, S.F.; Snaar-Jagalska, E.; Hogendoorn, P. & Schmidt, T. (2013), Understanding the Molecular Mechanism of Gradient Sensing, Biophysical Journal 104(2): 320A-320A.
- Anninga, J.K.; Picci, P.; Fiocco, M.; Kroon, H.M.J.A.; Vanel, D.; Alberghini, M.; Gelderblom, H. & Hogendoorn, P.C.W. (2013), Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup., Virchows Archiv 462(1): 109-20.
- Sarver, A.L.; Thayanithy, V.; Scott, M.C.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W.; Modiano, J.F. & Subramanian, S. (2013), MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma, Orphanet Journal of Rare Diseases 8: -.
- Vries, M. de; Briaire-de Bruijn, I.; Malessy, M.J.A.; Bruine, S.F.T. de; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2013), Tumor-associated macrophages are related to volumetric growth of vestibular schwannomas, Otology and Neurotology.
- Mohseny, A.B.; Cai, Y.P.; Kuijjer, M.; Xiao, W.; Akker, B. van den; Andrea, C.E. de; Jacobs, R.; Dijke, P. ten; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2012), The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma, European Journal of Cancer 48(18): 3429-3438.
- Berghuis, D.; Schilham, M.W.; Santos, S.J.; Savola, S.; Knowles, H.J.; Dirksen, U.; Schaefer, K.L.; Vakkila, J.; Hogendoorn, P.C.W. & Lankester, A.C. (2012), The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease., Clinical Sarcoma Research 2(1): 24.
- Cliteur, V.P.; Szuhai, K.; Baelde, H.J.; Dam, J. van; Gelderblom, H. & Hogendoorn, P.C. (2012), Paratesticular desmoplastic small round cell tumour: an unusual tumour with an unusual fusion; cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH., Clinical Sarcoma Research 2(1): 3.
- Romeo, S.; Bovee, J.V.M.G.; Kroon, H.M.; Tirabosco, R.; Natali, C.; Zanatta, L.; Sciot, R.; Mertens, F.; Athanasou, N.; Alberghini, M.; Szuhai, K.; Hogendoorn, P.C.W. & Tos, A.P.D. (2012), Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches, Virchows Archiv 461(5): 561-570.
- Szuhai, K. & Hogendoorn, P.C.W. (2012), 'The chicken or the egg?' dilemma strikes back for the controlling mechanism in chordoma, Journal of Pathology 228(3): 261-265.
- Kresse, S.H.; Rydbeck, H.; Skarn, M.; Namlos, H.M.; Barragan-Polania, A.H.; Cleton-Jansen, A.M.; Serra, M.; Liestol, K.; Hogendoorn, P.C.W.; Hovig, E.; Myklebost, O. & Meza-Zepeda, L.A. (2012), Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma, PLoS ONE 7(11): -.
- Woll, P.J.; Reichardt, P.; Cesne, A. le; Bonvalot, S.; Azzarelli, A.; Hoekstra, H.J.; Leahy, M.; Coevorden, F. van; Verweij, J.; Hogendoorn, P.C.W.; Ouali, M.; Marreaud, S.; Bramwell, V.H.C.; Hohenberger, P.; EORTC Soft Tissue Bone Sarcoma Grp & NCIC Clinical Trials Grp Sarcoma D (2012), Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
- Wang, W.L.; Patel, N.R.; Caragea, M.; Hogendoorn, P.C.W.; Lopez-Terrada, D.; Hornick, J.L. & Lazar, A.J. (2012), Expression of ERG, an Ets family transcription factor, identifies ERG-rearranged Ewing sarcoma, Modern Pathology 25(10): 1378-1383.
- Blay, J.Y.; Blomqvist, C.; Bonvalot, S.; Boukovinas, I.; Casali, P.G.; Alava, E. de; Tos, A.P. dei; Dirksen, U.; Duffaud, F.; Eriksson, M.; Fedenko, A.; Ferrari, A.; Ferrari, S.; Garcia del Muro, X.; Gelderblom, H.; Grimer, R.; Gronchi, A.; Hall, K.S.; Hassan, B.; Hogendoorn, P.; Hohenberger, P.; Issels, R.; Joensuu, H.; Jost, L.; Jurgens, H.; Kager, L.; Cesne, A. le; Leyvraz, S.; Martin, J.; Merimsky, O.; Nishida, O.; Picci, P.; Reichardt, P.; Rutkowski, P.; Schlemmer, M.; Sleijfer, S.; Stacchiotti, S.; Taminiau, A.; Wardelmann, E. & ESMO European Sarcoma Network Work (2012), Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology 23: 49-55.
- Blay, J.Y.; Blomqvist, C.; Bonvalot, S.; Boukovinas, I.; Casali, P.G.; Alava, E. de; Tos, A.P. dei; Dirksen, U.; Duffaud, F.; Eriksson, M.; Fedenko, A.; Ferrari, A.; Ferrari, S.; Garcia del Muro, X.; Gelderblom, H.; Grimer, R.; Gronchi, A.; Hall, K.S.; Hassan, B.; Hogendoorn, P.; Hohenberger, P.; Issels, R.; Joensuu, H.; Jost, L.; Jurgens, H.; Kager, L.; Cesne, A. le; Leyvraz, S.; Martin, J.; Merimsky, O.; Nishida, T.; Picci, P.; Reichardt, P.; Rutkowski, P.; Schlemmer, M.; Sleijfer, S.; Stacchiotti, S.; Taminiau, A.; Wardelmann, E. & ESMO European Sarcoma Network Working Grp (2012), Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology 23: 92-99.
- Andrea, C.E. de; Kroon, H.M.; Wolterbeek, R.; Romeo, S.; Rosenberg, A.E.; Young, B.R. de; Liegl, B.; Inwards, C.Y.; Hauben, E.; McCarthy, E.F.; Idoate, M.; Athanasou, N.A.; Jones, K.B.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2012), Interobserver reliability in the histopathological diagnosis of cartilaginous tumors in patients with multiple osteochondromas, Modern Pathology 25(9): 1275-1283.
- Jones, E.A.; Deininger, S.O.; Hogendoorn, P.C.W.; Deelder, A.M. & McDonnell, L.A. (2012), Imaging mass spectrometry statistical analysis, Journal of Proteomics 75(16): 4962-4989.
- Oosterwijk, J.G. van; Jong, D. de; Ruler, M.A.J.H. van; Hogendoorn, P.C.W.; Dijkstra, P.D.S.; Rijswijk, C.S.P. van; Machado, I.; Llombart-Bosch, A.; Szuhai, K. & Bovee, J.V.M.G. (2012), Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone, BMC Cancer 12: -.
- Lenos, K.; Grawenda, A.M.; Lodder, K.; Kuijjer, M.L.; Teunisse, A.F.A.S.; Repapi, E.; Grochola, L.F.; Bartel, F.; Hogendoorn, P.C.W.; Wuerl, P.; Taubert, H.; Cleton-Jansen, A.M.; Bond, G.L. & Jochemsen, A.G. (2012), Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer, Cancer Research 72(16): 4074-4084.
- Kuijjer, M.L.; Rydbeck, H.; Kresse, S.H.; Buddingh, E.P.; Lid, A.B.; Roelofs, H.; Burger, H.; Myklebost, O.; Hogendoorn, P.C.W.; Meza-Zepeda, L.A. & Cleton-Jansen, A.M. (2012), Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data, Genes, Chromosomes and Cancer 51(7): 696-706.
- Heijden, L. van der; Gibbons, C.L.M.H.; Dijkstra, P.D.S.; Kroep, J.R.; Rijswijk, C.S.P. van; Nout, R.A.; Bradley, K.M.; Athanasou, N.A.; Hogendoorn, P.C.W. & Sande, M.A.J. van de (2012), The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis).
- Verdegaal, S.H.M.; Brouwers, H.F.G.; Zwet, E.W. van; Hogendoorn, P.C.W. & Taminiau, A.H.M. (2012), Low-Grade Chondrosarcoma of Long Bones Treated with Intralesional Curettage Followed by Application of Phenol, Ethanol, and Bone-Grafting, Journal of Bone and Joint Surgery, American Volume 94A(13): 1201-1207.
- Mohseny, A.B.; Xiao, W.; Carvalho, R.; Spaink, H.P.; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2012), An osteosarcoma zebrafish model implicates Mmp-19 and Ets-1 as well as reduced host immune response in angiogenesis and migration, The Journal of Pathology 227(2): 245-253.
- Buddingh, E.P.; Ruslan, S.E.N.; Berghuis, D.; Gelderblom, H.; Anninga, J.K.; Hogendoorn, P.C.W.; Egeler, R.M.; Schilham, M.W. & Lankester, A.C. (2012), Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients, Cancer Immunology, Immunotherapy 61(6): 941-947.
- Vries, M. de; Hogendoorn, P.C.W.; Briaire-de Bruyn, I.; Malessy, M.J.A. & Mey, A.G.L. van der (2012), Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas, Virchows Archiv 460(6): 629-636.
- Whelan, J.S.; Jinks, R.C.; McTiernan, A.; Sydes, M.R.; Hook, J.M.; Trani, L.; Uscinska, B.; Bramwell, V.; Lewis, I.J.; Nooij, M.A.; Glabbeke, M. van; Grimer, R.J.; Hogendoorn, P.C.W.; Taminiau, A.H.M. & Gelderblom, H. (2012), Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials, Annals of Oncology 23(6): 1607-1616.
- Szuhai, K.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2012), Molecular pathology and its diagnostic use in bone tumors, Cancer Genetics 205(5): 193-204.
- Hemingway, F.; Kashima, T.G.; Mahendra, G.; Dhongre, A.; Hogendoorn, P.C.W.; Mertens, F. & Athanasou, N.A. (2012), Smooth muscle actin expression in primary bone tumours, Virchows Archiv 460(5): 525-534.
- Kovar, H.; Alonso, J.; Aman, P.; Aryee, D.N.T.; Ban, J.; Burchill, S.A.; Burdach, S.; Alava, E. de; Delattre, O.; Dirksen, U.; Fourtouna, A.; Fulda, S.; Helman, L.J.; Herrero-Martin, D.; Hogendoorn, P.C.W.; Kontny, U.; Lawlor, E.R.; Lessnick, S.L.; Llombart-Bosch, A.; Metzler, M.; Moriggl, R.; Niedan, S.; Potratz, J.; Redini, F.; Richter, G.H.S.; Riedmann, L.T.; Rossig, C.; Schafer, B.W.; Schwentner, R.; Scotlandi, K.; Sorensen, P.H.; Staege, M.S.; Tirode, F.; Toretsky, J.; Ventura, S.; Eggert, A. & Ladenstein, R. (2012), The first European interdisciplinary Ewing sarcoma research summit, Frontiers in Oncology 2: 1-10.
- Whelan, J.; Hook, J.; Bielack, S.S.; Marina, N.; Smeland, S.; Jovic, G.; Krailo, M.D.; Kuhne, T.; Eriksson, M.; Butterfass-Bahloul, T.; Teot, L.A.; Kager, L.; Gelderblom, H.; Hall, K.S.; Hogendoorn, P.C.W.; Sydes, M.R.; Bernstein, M.L. & EURAMOS (2012), EURAMOS-1 study: Recruitment, characteristics, and initial treatment of more than 2,000 patients (pts) with high-grade osteosarcoma, Journal of Clinical Oncology 30(15).
- Mackintosh, C.; Ordonez, J.L.; Garcia-Dominguez, D.J.; Sevillano, V.; Llombart-Bosch, A.; Szuhai, K.; Scotlandi, K.; Alberghini, M.; Sciot, R.; Sinnaeve, F.; Hogendoorn, P.C.W.; Picci, P.; Knuutila, S.; Dirksen, U.; Debiec-Rychter, M.; Schaefer, K.L. & Alava, E. de (2012), 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma, Oncogene 31(10): 1287-1298.
- McTiernan, A.; Jinks, R.C.; Sydes, M.R.; Uscinska, B.; Hook, J.M.; Glabbeke, M. van; Bramwell, V.; Lewis, I.J.; Taminiau, A.H.M.; Nooij, M.A.; Hogendoorn, P.C.W.; Gelderblom, H. & Whelan, J.S. (2012), Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup, European Journal of Cancer 48(5): 703-712.
- Andrea, C.E. de; Reijnders, C.M.A.; Kroon, H.M.; Jong, D. de; Hogendoorn, P.C.W.; Szuhai, K. & Bovee, J.V.M.G. (2012), Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT, Oncogene 31(9): 1095-1104.
- Wang, W.L.; Patel, N.R.; Caragea, M.; Lopez-Terrada, D.; Hogendoorn, P.C.W.; Hornick, J.L. & Lazar, A.J. (2012), Expression of ERG, an Ets Family Transcription Factor, Specifically Identifies ERG-Rearranged Ewing Sarcoma.
- Wang, W.L.; Patel, N.R.; Caragea, M.; Lopez-Terrada, D.; Hogendoorn, P.C.W.; Hornick, J.L. & Lazar, A.J. (2012), Expression of ERG, an Ets Family Transcription Factor, Specifically Identifies ERG-Rearranged Ewing Sarcoma.
- Wang, L.; Motoi, T.; Khanin, R.; Olshen, A.; Mertens, F.; Bridge, J.; Cin, P. dal; Antonescu, C.R.; Singer, S.; Hameed, M.; Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Socci, N. & Ladanyi, M. (2012), Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data, Genes, Chromosomes and Cancer 51(2): 127-139.
- Andrea, C.E. de; Kroon, H.M.; Wolterbeck, R.; Romeo, S.; Rosenberg, A.E.; DeYoung, B.R.; Liegl-Alzwanger, B.; Inwards, C.Y.; Hauben, E.; McCarthy, E.F.; Idoate, M.; Athanasou, N.A.; Jones, K.B.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2012), Interobserver Reliability in the Histopathological Diagnosis of Peripheral Cartilaginous Tumors in Patients with Multiple Osteochondromas: How Can We Improve Diagnostic Quality?
- Andrea, C.E. de; Kroon, H.M.; Wolterbeek, R.; Romeo, S.; Rosenbeig, A.E.; DeYoung, B.R.; Liegl-Atzwanger, B.; Inwards, C.Y.; Hauben, E.; McCarthy, E.; Idoate, M.; Athanason, N.A.; Jones, K.B.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2012), Interobserver Reliability in the Histopathological Diagnosis of Peripheral Cartilaginous Tumors in Patients with Multiple Osteochondromas: How Can We Improve Diagnostic Quality?
- Anninga, J.K.; Picci, P.; Kroon, H.M.; Vanel, D. & Hogendoorn, P.C.W. (2012), Osteosarcoma of the Hands and Feet: A Clinico-Pathologic Distinct Subgroup of OS?
- Anninga, J.K.; Picci, P.; Kroon, H.M.; Vanel, D. & Hogendoorn, P.C.W. (2012), Osteosarcoma of the Hands and Feet: A Clinico-Pathologic Distinct Subgroup of OS?
- Taylor, R.M.; Kashima, T.G.; Ferguson, D.J.; Szuhai, K.; Hogendoorn, P.C. & Athanasou, N.A. (2012), Analysis of stromal cells in osteofibrous dysplasia and adamantinoma of long bones, Modern Pathology 25(1): 56-64.
- Truong, H.H.; Sonneville, J. de; Ghotra, V.P.S.; Xiong, J.L.; Price, L.; Hogendoorn, P.C.W.; Spaink, H.H.; Water, B. van de & Danen, E.H.J. (2012), Automated microinjection of cell-polymer suspensions in 3D ECM scaffolds for high-throughput quantitative cancer invasion screens, Biomaterials 33(1): 181-188.
- Andrea, C.E. de & Hogendoorn, P.C.W. (2012), Epiphyseal growth plate and secondary peripheral chondrosarcoma: the neighbours matter, The Journal of Pathology 226(2): 219-228.
- Beletkaia, E.; Fenz, S.F.; Snaar-Jagalska, E.; Hogendoorn, P. & Schmidt, T. (2012), Molecular Mechanisms of Gradient Sensing in Ewing's Sarcoma Cells, Biophysical Journal 102(3): 513A-513A.
- Andrea, C.E. de; Wiweger, M.I.; Bovee, J.V.M.G.; Romeo, S. & Hogendoorn, P.C.W. (2012), Peripheral chondrosarcoma progression is associated with increased type X collagen and vascularisation, Virchows Archiv 460(1): 95-102.
- Pahl, J.H.W.; Ruslan, S.E.N.; Buddingh, E.P.; Santos, S.J.; Szuhai, K.; Serra, M.; Gelderblom, H.; Hogendoorn, P.C.W.; Egeler, R.M.; Schilham, M.W. & Lankester, A.C. (2012), Anti-EGFR Antibody Cetuximab Enhances the Cytolytic Activity of Natural Killer Cells toward Osteosarcoma, Clinical Cancer Research 18(2): 432-441.
- Wiweger, M.I.; Zhao, Z.; Merkesteyn, R.J.P. van; Roehl, H.H. & Hogendoorn, P.C.W. (2012), HSPG-Deficient Zebrafish Uncovers Dental Aspect of Multiple Osteochondromas, PLoS ONE 7(1): -.
- Truong H.H., Sonneville J. de, Ghotra V.P., Xiong J., Price L., Hogendoorn P.C., Spaink H.P., Water B. van de & Danen E.H. (2012), Automated microinjection of cell-polymer suspensions in 3D ECM scaffolds for high-throughput quantitative cancer invasion screens, Biomaterials 33(1): 181-188.
- Gelderblom, A.J. (2012), Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment, Clinical Sarcoma Research.
- Maldegem, A.M. van; Bhosale, A.; Gelderblom, H.J.; Hogendoorn, P.C.W. & Hassan, A.B. (2012), Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment., Clinical Sarcoma Research.
- Vries, M. de; Hogendoorn, P.C.W.; Briaire-de Bruyn, I.; Malessy, M.J.A. & Mey, A.G.L. van der (2012), Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas, Virchows Archiv 460.
- Verdegaal, S.H.M.; Bovee, J.V.M.G.; Pansuriya, T.C.; Grimer, R.J.; Ozger, H.; Jutte, P.C.; San Julian, M.; Biau, D.J.; Geest, I.C.M. van der; Leithner, A.; Streitburger, A.; Klenke, F.M.; Gouin, F.G.; Campanacci, D.A.; Marec-Berard, P.; Hogendoorn, P.C.W.; Brand, R. & Taminiau, A.H.M. (2011), Incidence, predictive factors, and prognosis of chondrosarcoma in patients with ollier disease and maffucci syndrome: an international multicenter study of 161 patients., The Oncologist 16(12): 1771-9.
- de Jong D, Verbeke SLj, Meijer D, Hogendoorn PC, Bovee JV & Szuhai K (2011), Opening the archives for state of the art tumour genetic research: sample processing for array-CGH using decalcified, formalin-fixed, paraffin-embedded tissue-derived DNA samples., BMC Research Notes 4: 1.
- Anninga, J.K.; Gelderblom, H.; Fiocco, M.; Kroep, J.R.; Taminiau, A.H.M.; Hogendoorn, P.C.W. & Egeler, R.M. (2011), Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?, European Journal of Cancer 47(16): 2431-2445.
- He, S.N.; Krens, S.F.G.; Zhan, H.Q.; Gong, Z.Y.; Hogendoorn, P.C.W.; Spaink, H.P. & Snaar-Jagalska, B.E. (2011), A Delta Raf1-ER-inducible oncogenic zebrafish liver cell model identifies hepatocellular carcinoma signatures, Journal of Pathology 225(1): 19-28.
- Pansuriya, T.C.; Oosting, J.; Verdegaal, S.H.M.; Flanagan, A.M.; Sciot, R.; Kindblom, L.G.; Hogendoorn, P.C.W.; Szuhai, K. & Bovee, J.V.M.G. (2011), Maffucci Syndrome: A Genome-Wide Analysis Using High Resolution Single Nucleotide Polymorphism and Expression Arrays on Four Cases, Genes, Chromosomes and Cancer 50(9): 673-679.
- Jones, E.A.; Remoortere, A. van; Zeijl, R.J.M. van; Hogendoorn, P.C.W.; Bovee, J.V.M.G.; Deelder, A.M. & McDonnell, L.A. (2011), Multiple Statistical Analysis Techniques Corroborate Intratumor Heterogeneity in Imaging Mass Spectrometry Datasets of Myxofibrosarcoma, PLoS ONE 6(9): -.
- Kuijjer, M.L.; Namlos, H.M.; Hauben, E.I.; Machado, I.; Kresse, S.H.; Serra, M.; Llombart-Bosch, A.; Hogendoorn, P.C.W.; Meza-Zepeda, L.A.; Myklebost, O. & Cleton-Jansen, A.M. (2011), mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts, BMC Medical Genomics 4: -.
- Mohseny, A.B.; Machado, I.; Cai, Y.P.; Schaefer, K.L.; Serra, M.; Hogendoorn, P.C.W.; Llombart-Bosch, A. & Cleton-Jansen, A.M. (2011), Functional characterization of osteosarcoma cell lines provides representative models to study the human disease, Laboratory Investigation 91(8): 1195-1205.
- Maggiani, F.; Forsyth, R.; Hogendoorn, P.C.W.; Krenacs, T. & Athanasou, N.A. (2011), The immunophenotype of osteoclasts and macrophage polykaryons, Journal of Clinical Pathology 64(8): 701-705.
- Amary, M.F.; Bacsi, K.; Maggiani, F.; Damato, S.; Halai, D.; Berisha, F.; Pollock, R.; O'Donnell, P.; Grigoriadis, A.; Diss, T.; Eskandarpour, M.; Presneau, N.; Hogendoorn, P.C.W.; Futreal, A.; Tirabosco, R. & Flanagan, A.M. (2011), IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours, The Journal of Pathology 224(3): 334-343.
- Kashima, T.G.; Dongre, A.; Flanagan, A.M.; Hogendoorn, P.C.W.; Taylor, R. & Athanasou, N.A. (2011), Podoplanin expression in adamantinoma of long bones and osteofibrous dysplasia, Virchows Archiv 459(1): 41-46.
- Nieuwenhuis, M.H.; Casparie, M.; Mathus-Vliegen, L.M.H.; Dekkers, O.M.; Hogendoorn, P.C.W. & Vasen, H.F.A. (2011), A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses, International Journal of Cancer 129(1): 256-261.
- Andrea, C.E. de; Prins, F.A.; Wiweger, M.I. & Hogendoorn, P.C.W. (2011), Growth plate regulation and osteochondroma formation: insights from tracing proteoglycans in zebrafish models and human cartilage, Journal of Pathology 224(2): 160-168.
- Jennes, I.; Jong, D. de; Mees, K.; Hogendoorn, P.C.W.; Szuhai, K. & Wuyts, W. (2011), Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 Multiple Osteochondromas families, BMC Medical Genetics 12.
- Balke, M.; Neumann, A.; Szuhai, K.; Agelopoulos, K.; August, C.; Gosheger, G.; Hogendoorn, P.C.W.; Athanasou, N.; Buerger, H. & Hagedorn, M. (2011), A short-term in vivo model for giant cell tumor of bone, BMC Cancer 11.
- Martins, A.S.; Ordonez, J.L.; Amaral, A.T.; Prins, F.; Floris, G.; Debiec-Rychter, M.; Hogendoorn, P.C.W. & Alava, E. de (2011), IGF1R Signaling in Ewing Sarcoma Is Shaped by Clathrin-/Caveolin-Dependent Endocytosis, PLoS ONE 6(5): -.
- Buddingh, E.P.; Schilham, M.W.; Eriaty, S.; Ruslan, N.; Berghuis, D.; Szuhai, K.; Suurmond, J.; Taminiau, A.H.M.; Gelderblom, H.; Egeler, R.M.; Serra, M.; Hogendoorn, P.C.W. & Lankester, A.C. (2011), Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells, Cancer Immunology, Immunotherapy 60(4): 575-586.
- Gelderblom, H.; Jinks, R.C.; Sydes, M.; Bramwell, V.H.C.; Glabbeke, M. van; Grimer, R.J.; Hogendoorn, P.C.W.; McTiernan, A.; Lewis, I.J.; Nooij, M.A.; Taminiau, A.H.M.; Whelan, J. & European Osteosarcoma Intergrp (2011), Survival after recurrent osteosarcoma: Data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials, European Journal of Cancer 47(6): 895-902.
- Buddingh, E.P.; Kuijjer, M.L.; Duim, R.A.J.; Burger, H.; Agelopoulos, K.; Myklebost, O.; Serra, M.; Mertens, F.; Hogendoom, P.C.W.; Lankester, A.C. & Cleton-Jansen, A.M. (2011), Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents, Clinical Cancer Research 17(8): 2110-2119.
- Wiweger, M.I.; Avramut, C.M.; Andrea, C.E. de; Prins, F.A.; Koster, A.J.; Ravelli, R.B.G. & Hogendoom, P.C.W. (2011), Cartilage ultrastructure in proteoglycan-deficient zebrafish mutants brings to light new candidate genes for human skeletal disorders, Journal of Pathology 223(4): 531-542.
- Mohseny, A.B. & Hogendoorn, P.C.W. (2011), Concise Review: Mesenchymal Tumors: When Stem Cells Go Mad, Stem Cells 29(3): 397-403.
- Berghuis, D.; Santos, S.J.; Baelde, H.J.; Taminiau, A.H.M.; Egeler, R.M.; Schilham, M.W.; Hogendoorn, P.C.W. & Lankester, A.C. (2011), Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression, Journal of Pathology 223(3): 347-357.
- Presneau, N.; Shalaby, A.; Ye, H.T.; Pillay, N.; Halai, D.; Idowu, B.; Tirabosco, R.; Whitwell, D.; Jacques, T.S.; Kindblom, L.G.; Bruderlein, S.; Moller, P.; Leithner, A.; Liegl, B.; Amary, F.M.; Athanasou, N.N.; Hogendoorn, P.C.W.; Mertens, F.; Szuhai, K. & Flanagan, A.M. (2011), Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study, Journal of Pathology 223(3): 327-335.
- Shalaby, A.; Presneau, N.; Ye, H.T.; Halai, D.; Berisha, F.; Idowu, B.; Leithner, A.; Liegl, B.; Briggs, T.R.W.; Bacsi, K.; Kindblom, L.G.; Athanasou, N.; Amary, M.F.; Hogendoorn, P.C.W.; Tirabosco, R. & Flanagan, A.M. (2011), The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target, Journal of Pathology 223(3): 336-346.
- Szuhai, K.; Jennes, I.; Jong, D. de; Bovee, J.V.M.G.; Wiweger, M.; Wuyts, W. & Hogendoorn, P.C.W. (2011), Tiling Resolution Array-CGH Shows That Somatic Mosaic Deletion of the EXT Gene is Causative in EXT Gene Mutation Negative Multiple Osteochondromas Patients, Human Mutation 32(2): E2036-E2049.
- Ladanyi, M. & Hogendoorn, P.C.W. (2011), Cancer biology and genomics: translating discoveries, transforming pathology, Journal of Pathology 223(2): 99-101.
- Pardali, E.; Schaft, D.W.J. van der; Wiercinska, E.; Gorter, A.; Hogendoorn, P.C.W.; Griffioen, A.W. & Dijke, P. ten (2011), Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma, Oncogene 30(3): 334-345.
- Verbeke, S.L.J.; Bertoni, F.; Bacchini, P.; Sciot, R.; Fletcher, C.D.M.; Kroon, H.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2011), Distinct histological features characterize primary angiosarcoma of bone, Histopathology 58(2): 254-264.
- Kroep, J.R.; Ouali, M.; Gelderblom, H.; Cesne, A. le; Dekker, T.J.A.; Glabbeke, M. van; Hogendoorn, P.C.W. & Hohenberger, P. (2011), First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study, Annals of Oncology 22(1): 207-214.
- Picci, P.; Sieberova, G.; Alberghini, M.; Balladelli, A.; Vanel, D.; Hogendoorn, P.C.W. & Mercuri, M. (2011), Late sarcoma development after curettage and bone grafting of benign bone tumors, European Journal of Radiology 77(1): 19-25.
- Pansuriya, T.C.; Oosting, J.; Krenacs, T.; Taminiau, A.H.M.; Verdegaal, S.H.M.; Sangiorgi, L.; Sciot, R.; Hogendoorn, P.C.W.; Szuhai, K. & Bovee, J.V.M.G. (2011), Genome-wide analysis of Ollier disease: Is it all in the genes?, Orphanet Journal of Rare Diseases 6.
- Meijer, D.; Gelderblom, H.; Karperien, M.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2011), Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo, Clinical Sarcoma Research 1.
- Mertens, F.; Romeo, S.; Bovee, J.V.M.G.; Tirabosco, R.; Athanasou, N.; Alberghini, M.; Hogendoorn, P.C.W.; Tos, A.P.D.; Sciot, R.; Domanski, H.A.; Astrom, K.; Mandahl, N. & Debiec-Rychter, M. (2011), Reclassification and subtyping of so-called malignant fibrous histiocytoma of bone: comparison with cytogenetic features, Clinical Sarcoma Research 1.
- Heyning, F.H.; Jansen, P.M.; Hogendoorn, P.C.W. & Szuhai, K. (2010), Array-based comparative genomic hybridisation analysis reveals recurrent chromosomal alterations in primary diffuse large B cell lymphoma of bone, Journal of Clinical Pathology 63(12): 1095-1100.
- Willems, S.M.; Remoortere, A. van; Zeijl, R. van; Deelder, A.M.; McDonnell, L.A. & Hogendoorn, P.C.W. (2010), Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity, Journal of Pathology 222(4): 400-409.
- Mohseny, A.B.; Tieken, C.; Velden, P.A. van der; Szuhai, K.; Andrea, C. de; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2010), Small Deletions but not Methylation Underlie CDKN2A/p16 Loss of Expression in Conventional Osteosarcoma, Genes, Chromosomes and Cancer 49(12): 1095-1103.
- Diaz-Romero, J.; Romeo, S.; Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Heini, P.F. & Mainil-Varlet, P. (2010), Hierarchical Clustering of Flow Cytometry Data for the Study of Conventional Central Chondrosarcoma, Journal of Cellular Physiology 225(2): 601-611.
- Reijnders, C.M.A.; Waaijer, C.J.F.; Hamilton, A.; Buddingh, E.P.; Dijkstra, S.P.D.; Ham, J.; Bakker, E.; Szuhai, K.; Karperien, M.; Hogendoorn, P.C.W.; Stringer, S.E. & Bovee, J.V.M.G. (2010), No Haploinsufficiency but Loss of Heterozygosity for EXT in Multiple Osteochondromas, American Journal of Pathology 177(4): 1946-1957.
- Romeo, S.; Duim, R.A.J.; Bridge, J.A.; Mertens, F.; Jong, D. de; Cin, P. dal; Wijers-Koster, P.M.; Debiec-Rychter, M.; Sciot, R.; Rosenberg, A.E.; Szuhai, K. & Hogendoorn, P.C.W. (2010), Heterogeneous and Complex Rearrangements of Chromosome Arm 6q in Chondromyxoid Fibroma Delineation of Breakpoints and Analysis of Candidate Target Genes, American Journal of Pathology 177(3): 1365-1376.
- Willems, S.M.; Schrage, Y.M.; Briaire-de Bruijn, I.H.; Szuhai, K.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2010), Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option, Molecular Cancer 9.
- Dewaele, B.; Floris, G.; Finalet-Ferreiro, J.; Fletcher, C.D.; Coindre, J.M.; Guillou, L.; Hogendoorn, P.C.W.; Wozniak, A.; Vanspauwen, V.; Schoffski, P.; Marynen, P.; Vandenberghe, P.; Sciot, R. & Debiec-Rychter, M. (2010), Coactivated Platelet-Derived Growth Factor Receptor alpha and Epidermal Growth Factor Receptor Are Potential Therapeutic Targets in Intimal Sarcoma, Cancer Research 70(18): 7304-7314.
- Nieuwenhuis, M.H.; Casparie, M.; Mathus-Vliegen, L.M.H.; Dekkers, O.M.; Hogendoorn, P.C.W. & Vasen, H.F.A. (2010), A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses., International Journal of Cancer.
- Novelli, M.; Rossi, S.; Rodriguez-Justo, M.; Taniere, P.; Seddon, B.; Toffolatti, L.; Sartor, C.; Hogendoorn, P.C.W.; Sciot, R.; Glabbeke, M. van; Verweij, J.; Blay, J.Y.; Hohenberger, P.; Flanagan, A. & Tos, A.P. dei (2010), DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours, Histopathology 57(2): 259-270.
- Balke, M.; Campanacci, L.; Gebert, C.; Picci, P.; Gibbons, M.; Taylor, R.; Hogendoorn, P.; Kroep, J.; Wass, J. & Athanasou, N. (2010), Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone, BMC Cancer 10.
- Dongen, M. van; Savage, N.D.L.; Jordanova, E.S.; Briaire-de Bruijn, I.H.; Walburg, K.V.; Ottenhoff, T.H.M.; Hogendoorn, P.C.W.; Burg, S.H. van der; Gelderblom, H. & Hall, T. van (2010), Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors, International Journal of Cancer 127(4): 899-909.
- Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Wunder, J.S. & Alman, B.A. (2010), Cartilage tumours and bone development: molecular pathology and possible therapeutic targets, Nature Reviews Cancer 10(7): 481-488.
- Andrea, C.E. de; Wiweger, M.; Prins, F.; Bovee, J.V.M.G.; Romeo, S. & Hogendoorn, P.C.W. (2010), Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma, Laboratory Investigation 90(7): 1091-1101.
- Verbeke, S.L.J.; Fletcher, C.D.M.; Alberghini, M.; Daugaard, S.; Flanagan, A.M.; Parratt, T.; Kroon, H.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2010), A Reappraisal of Hemangiopericytoma of Bone; Analysis of Cases Reclassified as Synovial Sarcoma and Solitary Fibrous Tumor of Bone, American Journal of Surgical Pathology 34(6): 777-783.
- Hogendoorn, P.C.W.; Athanasou, N.; Bielack, S.; Alava, E. de; Tos, A.P.D.; Ferrari, S.; Gelderblom, H.; Grimer, R.; Hall, K.S.; Hassan, B.; Hogendoorn, P.C.W.; Jurgens, H.; Paulussen, M.; Rozeman, L.; Taminiau, A.H.M.; Whelan, J.; Vanel, D. & ESMO EUROBONET Working Grp (2010), Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
- Hogendoorn, P.C.W.; Athanasou, N.; Bielack, S.; Alava, E. de; Tos, A.P.D.; Ferrari, S.; Gelderblom, H.; Grimer, R.; Hall, K.S.; Hassan, B.; Hogendoorn, P.C.W.; Jurgens, H.; Paulussen, M.; Rozeman, L.; Taminiau, A.H.M.; Whelan, J.; Vanel, D. & ESMO EUROBONET Working Grp (2010), Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology 21: v204v213.
- Boeuf, S.; Bovee, J.V.M.G.; Lehner, B.; Hogendoorn, P.C.W. & Richter, W. (2010), Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours, Histopathology 56(5): 641-651.
- Deley, M.C. le; Delattre, O.; Schaefer, K.L.; Burchill, S.A.; Koehler, G.; Hogendoorn, P.C.W.; Lion, T.; Poremba, C.; Marandet, J.; Ballet, S.; Pierron, G.; Brownhill, S.C.; Nesslbock, M.; Ranft, A.; Dirksen, U.; Oberlin, O.; Lewis, I.J.; Craft, A.W.; Jurgens, H. & Kovar, H. (2010), Impact of EWS-ETS Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-EWING 99 Trial, Journal of Clinical Oncology 28(12): 1982-1988.
- Egeler, R.M.; Halteren, A.G.S. van; Hogendoorn, P.C.W.; Laman, J.D. & Leenen, P.J.M. (2010), Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage.
- Egeler, R.M.; Halteren, A.G.S. van; Hogendoorn, P.C.W.; Laman, J.D. & Leenen, P.J.M. (2010), Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage, Immunological Reviews 234: 213-232.
- Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2010), Molecular pathology of sarcomas: concepts and clinical implications, Virchows Archiv 456(2): 193-199.
- Buddingh, E.P.; Anninga, J.K.; Versteegh, M.I.M.; Taminiau, A.H.M.; Egeler, R.M.; Rijswijk, C.S.P. van; Hogendoorn, P.C.W.; Lankester, A.C. & Gelderblom, H. (2010), Prognostic factors in pulmonary metastasized high-grade osteosarcoma., Pediatric Blood and Cancer 54(2): 216-21.
- Buddingh, E.P.; Anninga, J.K.; Versteegh, M.I.M.; Taminiau, A.H.M.; Egeler, R.M.; Rijswijk, C.S.P. van; Hogendoorn, P.C.W.; Lankester, A.C. & Gelderblom, H. (2010), Prognostic Factors in Pulmonary Metastasized High-Grade Osteosarcoma, Pediatric Blood and Cancer 54(2): 216-221.
- Willems, S.M.; Wiweger, M.; Roggen, J.F.G. van & Hogendoorn, P.C.W. (2010), Running GAGs: myxoid matrix in tumor pathology revisited, Virchows Archiv 456(2): 181-192.
- Subramanian, S.; Thayanithy, V.; West, R.B.; Lee, C.H.; Beck, A.H.; Zhu, S.; Downs-Kelly, E.; Montgomery, K.; Goldblum, J.R.; Hogendoom, P.C.W.; Corless, C.L.; Oliveira, A.M.; Dry, S.M.; Nielsen, T.O.; Rubin, B.P.; Fletcher, J.A.; Fletcher, C.D.M. & Rijn, M. van de (2010), Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours, Journal of Pathology 220(1): 58-70.
- Ottaviano, L.; Schaefer, K.L.; Gajewski, M.; Huckenbeck, W.; Baldus, S.; Rogel, U.; Mackintosh, C.; Alava, E. de; Myklebost, O.; Kresse, S.H.; Meza-Zepeda, L.A.; Serra, M.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W.; Buerger, H.; Aigner, T.; Gabbert, H.E. & Poremba, C. (2010), Molecular Characterization of Commonly Used Cell Lines for Bone Tumor Research: A Trans-European EuroBoNet Effort, Genes, Chromosomes and Cancer 49(1): 40-51.
- Sleijfer, S.; Ouali, M.; Glabbeke, M. van; Krarup-Hansen, A.; Rodenhuis, S.; Cesne, A. le; Hogendoorn, P.C.W.; Verweij, J. & Blay, J.Y. (2010), Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG), European Journal of Cancer 46(1): 72-83.
- Dirk Engberts & Pancras Hogendoorn (2010), Een onrustig bezit, Museumtijdschrift.
- Jansen-Landheer MLEA, Krijnen P, Oostindier MJ, Kloosterman-Boele WM, Noordijk EM, Nooij MA, Steup WH, Taminiau AHM, Vree R, Hogendoorn PCW, Tollenaar RAEM & Gelderblom H (2009), Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: A population-based study, EJSO - European Journal of Surgical Oncology 35(12): 1326-1332.
- Hall, P.A.; Poulsom, R.; Coates, P.J.; , M.Q. du; Hogendoom, P.C.W.; Jones, L.J.; Ladanyi, M.; Murray, G.I. & Niedobitek, G. (2009), The Journal of Pathology 2008 Jeremy Jass Prize for Research Excellence in Pathology, Journal of Pathology 219(4): 393-395.
- Rozeman, L.B.; Bruijn, I.H.B. de; Bacchini, P.; Staals, E.L.; Bertoni, F.; Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2009), Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes, Modern Pathology 22(11): 1489-1498.
- Mohseny AB, Szuhai K, Romeo S, Buddingh EP, Briaire-de Bruijn I, de Jong D, van Pel M, Cleton-Jansen AM & Hogendoorn PCW (2009), Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2, Journal of Pathology 219(3): 294-305.
- Cleton-Jansen, A.M.; Anninga, J.K.; Briaire-de Bruijn, I.H.; Romeo, S.; Oosting, J.; Egeler, R.M.; Gelderblom, H.; Taminiau, A.H.M. & Hogendoorn, P.C.W. (2009), Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways, British Journal of Cancer 101(11): 1909-1918.
- Bayley, J.P.; Minderhout, I. van; Hogendoorn, P.C.W.; Cornelisse, C.J.; Wal, A. van der; Prins, F.A.; Teppema, L.; Dahan, A.; Devilee, P. & Taschner, P.E.M. (2009), Sdhd and Sdhd/H19 Knockout Mice Do Not Develop Paraganglioma or Pheochromocytoma, PLoS ONE 4(11).
- Romeo, S.; Szuhai, K.; Nishimori, I.; Ijszenga, M.; Wijers-Koster, P.; Taminiau, A.H.M. & Hogendoorn, P.C.W. (2009), A balanced t(5;17) (p15;q22-23) in chondroblastoma: frequency of the re-arrangement and analysis of the candidate genes, BMC Cancer 9.
- Giaccone, G.; Rajan, A.; Ruijter, R.; Smit, E.; Groeningen, C. van & Hogendoorn, P.C.W. (2009), Imatinib Mesylate in Patients with WHO B3 Thymomas and Thymic Carcinomas, Journal of Thoracic Oncology 4(10): 1270-1273.
- Romeo S, Hogendoorn PCW & Dei Tos AP (2009), Benign Cartilaginous Tumors of Bone From Morphology to Somatic and Germ-line Genetics, Advances in Anatomic Pathology 16(5): 307-315.
- Schrage, Y.M.; Lam, S.; Jochemsen, A.G.; Cleton-Jansen, A.M.; Taminiau, A.H.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2009), Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro, Journal of Cellular and Molecular Medicine 13(9A): 2843-2852.
- Heyning FH, Hogendoorn PCW, Kramer MHH, Holland CTQ, Dreef E & Jansen PM (2009), Primary lymphoma of bone: extranodal lymphoma with favourable survival independent of germinal centre, post-germinal centre or indeterminate phenotype, Journal of Clinical Pathology 62(9): 820-824.
- Reichardt P, Hogendoorn PCW, Tamborini E, Loda M, Gronchi A, Poveda A & Schoffski P (2009), Gastrointestinal Stromal Tumors I: Pathology, Pathobiology, Primary Therapy, and Surgical Issues, Seminars in Oncology 36(4): 290-301.
- Cesne, A. le; Glabbeke, M. van; Verweij, J.; Casali, P.G.; Findlay, M.; Reichardt, P.; Issels, R.; Judson, I.; Schoffski, P.; Leyvraz, S.; Bui, B.; Hogendoorn, P.C.W.; Sciot, R. & Blay, J.Y. (2009), Absence of Progression As Assessed by Response Evaluation Criteria in Solid Tumors Predicts Survival in Advanced GI Stromal Tumors Treated With Imatinib Mesylate: The Intergroup EORTC-ISG-AGITG Phase III Trial, Journal of Clinical Oncology 27(24): 3969-3974.
- Schrage, Y.M.; Briaire-de Bruijn, I.H.; Miranda, N.F.C.C. de; Oosterwijk, J. van; Taminiau, A.H.M.; Wezel, T. van; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2009), Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment, Cancer Research 69(15): 6216-6222.
- Willems, S.M.; Mohseny, A.B.; Balog, C.; Sewrajsing, R.; Briaire-de Bruijn, I.H.; Knijnenburg, J.; Cleton-Jansen, A.M.; Sciot, R.; Fletcher, C.D.M.; Deelder, A.M.; Szuhai, K.; Hensbergen, P.J. & Hogendoorn, P.C.W. (2009), Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix, Journal of Cellular and Molecular Medicine 13(7): 1291-1301.
- Ray-Coquard, I.; Cropet, C.; Glabbeke, M. van; Sebban, C.; Cesne, A. le; Judson, I.; Tredan, O.; Verweij, J.; Biron, P.; Labidi, I.; Guastalla, J.P.; Bachelot, T.; Perol, D.; Chabaud, S.; Hogendoorn, P.C.W.; Cassier, P.; Dufresne, A.; Blays, J.Y. & European Org Res & Treatment Canc (2009), Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas, Cancer Research 69(13): 5383-5391.
- Moskovszky L, Szuhai K, Krenacs T, Hogendoorn PCW, Szendroi M, Benassi MS, Kopper L, Fule T & Sapi Z (2009), Genomic Instability in Giant Cell Tumor of Bone. A Study of 52 Cases Using DNA Ploidy, Relocalization FISH, and Array-CGH Analysis, Genes, Chromosomes and Cancer 48(6): 468-479.
- van Bezooijen RL, Bronckers AL, Gortzak RA, Hogendoorn PCW, van der Wee-Pals L, Balemans W, Oostenbroek HJ, Van Hul W, Hamersma H, Dikkers FG, Hamdy NAT, Papapoulos SE & Lowik CWGM (2009), Sclerostin in Mineralized Matrices and van Buchem Disease, Journal of Dental Research 88(6): 569-574.
- Romeo, S.; Debiec-Rychter, M.; Glabbeke, M. van; Paassen, H. van; Comite, P.; Eijk, R. van; Oosting, J.; Verweij, J.; Terrier, P.; Schneider, U.; Sciot, R.; Blay, J.Y.; Hogendoorn, P.C.W. & European Org Res Treatment Canc (2009), Cell Cycle/Apoptosis Molecule Expression Correlates with Imatinib Response in Patients with Advanced Gastrointestinal Stromal Tumors, Clinical Cancer Research 15(12): 4191-4198.
- Kroep JR, Bovee JVMG, van der Molen AJ, Hogendoorn PCW & Gelderblom H (2009), Extra-abdominal subcutaneous metastasis of a gastrointestinal stromal tumor: report of a case and a review of the literature, Journal of Cutaneous Pathology 36(5): 565-569.
- Hensen, E.F.; Goeman, J.J.; Oosting, J.; Mey, A.G.L. van der; Hogendoorn, P.C.W.; Cremers, C.W.R.J.; Devilee, P. & Cornelisse, C.J. (2009), Similar gene expression profiles of sporadic, PGL2-, and SDHD-linked paragangliomas suggest a common pathway to tumorigenesis, BMC Medical Genomics 2.
- Reijnders, C.M.A.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2009), The molecular and cellular basis exostosis formation in hereditary multiple exostoses, International Journal of Experimental Pathology 90(2): 190-191.
- Hallor, K.H.; Staaf, J.; Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Cleton-Jansen, A.M.; Knuutila, S.; Savola, S.; Niini, T.; Brosjo, O.; Bauer, H.C.F.; Steyern, F.V. von; Jonsson, K.; Skorpil, M.; Mandahl, N. & Mertens, F. (2009), Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors, Clinical Cancer Research 15(8): 2685-2694.
- Szuhai, K.; Ijszenga, M.; Jong, D. de; Karseladze, A.; Tanke, H.J. & Hogendoorn, P.C.W. (2009), The NFATc2 Gene Is Involved in a Novel Cloned Translocation in a Ewing Sarcoma Variant That Couples Its Function in Immunology to Oncology, Clinical Cancer Research 15(7): 2259-2268.
- Schrage, Y.M.; Hameetman, L.; Szuhai, K.; Cleton-Jansen, A.M.; Taminiau, A.H.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2009), Aberrant Heparan Sulfate Proteoglycan Localization, Despite Normal Exostosin, in Central Chondrosarcoma, American Journal of Pathology 174(3): 979-988.
- da Costa CET, Szuhai K, van Eijk R, Hoogeboom M, Sciot R, Mertens F, Bjorgvinsdottir H, Debiec-Rychter M, de Krijger RR & Hogendoorn PCW (2009), No Genomic Aberrations in Langerhans Cell Histiocytosis as Assessed by Diverse Molecular Technologies, Genes, Chromosomes and Cancer 48(3): 239-249.
- Beerman H, van Dorst EBL, Kuenen-Boumeester V & Hogendoorn PCW (2009), Superior performance of liquid-based versus conventional cytology in a population-based cervical cancer screening program, Gynecologic Oncology 112(3): 572-576.
- Boeck, G. de; Forsyth, R.G.; Praet, M. & Hogendoom, P.C.W. (2009), Telomere-associated proteins: cross-talk between telomere maintenance and telomere-lengthening mechanisms, Journal of Pathology 217(3): 327-344.
- Eefting D, Schrage YM, Geirnaerdt MJA, Le Cessie S, Taminiau AHM, Bovee JVMG & Hogendoorn PCW (2009), Assessment of Interobserver Variability and Histologic Parameters to Improve Reliability in Classification and Grading of Central Cartilaginous Tumors, American Journal of Surgical Pathology 33(1): 50-57.
- Forsyth, R.G.; Boeck, G. de; Baelde, J.J.; Taminiau, A.H.M.; Uyttendaele, D.; Roels, H.; Praet, M.M. & Hogendoorn, P.C.W. (2009), CD33+CD14-Phenotype Is Characteristic of Multinuclear Osteoclast-Like Cells in Giant Cell Tumor of Bone, Journal of Bone and Mineral Research 24(1): 70-77.
- Szuhai K, IJszenga M, de Jong D, Karseladze A, Tanke HJ & Hogendoorn PCW (2009), Novel, Cloned Translocation Partner in Ewing Sarcoma Couples Its Function to Oncology, Laboratory Investigation 89: 23A23A.
- Ye, D.; Kraaijeveld, A.O.; Grauss, R.W.; Willems, S.M.; Vark-van der Zee, L.C. van; Jager, S.C.A. de; Jauhiainen, M.; Kuivenhoven, J.A.; Dallinga-Thie, G.M.; Atsma, D.E.; Hogendoorn, P.C.W.; Biessen, E.A.L.; Berkel, T.J.C. van; Jukema, J.W. & Eck, M. van (2008), Reduced leucocyte cholesteryl ester transfer protein expression in acute coronary syndromes, Journal of Internal Medicine 264(6).
- Schlemmer M, Reichardt P, Verweij J, Hartmann JT, Judson I, Thyss A, Hogendoorn PCW, Marreaud S, Van Glabbeke M & Blay JY (2008), Paclitaxel in patients with advanced angiosarcomas of soft tissue: A retrospective study of the EORTC soft tissue and bone sarcoma group, European Journal of Cancer 44(16).
- Verdegaal SHM, Corver WE, Hogendoorn PCW & Taminiau AHM (2008), The cytotoxic effect of phenol and ethanol on the chondrosarcoma-derived cell line OUMS-27 AN IN VITRO EXPERIMENT, Journal of Bone and Joint Surgery, British Volume 90B(11).
- Boeuf S, Kunz P, Hennig T, Lehner B, Hogendoorn PCW, Bovee JVMG & Richter W (2008), A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma, Journal of Pathology 216(2).
- Sciot R, Debiec-Rychter M, Daugaard S, Fisher C, Collin F, van Glabbeke M, Verweij J, Blay JY & Hogendoorn PCW (2008), Distribution and prognostic value of histopathologic data and immunohistochemical markers in gastrointestinal stromal tumours (GISTs): An analysis of the EORTC phase III trial of treatment of metastatic GISTs with imatinib mesylate, European Journal of Cancer 44(13).
- Verhoeven DHJ, de Hooge ASK, Mooiman ECK, Santos SJ, ten Dam MM, Gelderblom H, Melief CJM, Hogendoorn PCW, Egeler RM, van Tol MJD, Schilham MW & Lankester AC (2008), NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways, Molecular Immunology 45(15).
- van den Berg H, Slaar A, Kroon HM, Taminiau AHM & Hogendoorn P (2008), Results of Diagnostic Review in Pediatric Bone Tumors and Tumorlike Lesions, Journal of Pediatric Orthopaedics 28(5): 561-564.
- Willems SM, Schrage YM, Baelde JJ, Bruijn IBD, Mohseny A, Sciot R, Bovee JVMG & Hogendoorn PCW (2008), Myxoid tumours of soft tissue: the so-called myxoid extracellular matrix is heterogeneous in composition, Histopathology 52(4).
- van den Berg H, Kroon HM, Slaar A & Hogendoorn P (2008), Incidence of biopsy-proven bone tumors in children - A report based on the dutch pathology registration "PALGA", Journal of Pediatric Orthopaedics 28(1).
- Edwards JR, Williams K, Kindblom LG, Meis-Kindblom JM, Hogendoorn PCW, Hughes D, Forsyth RG, Jackson D & Athanasou NA (2008), Lymphatics and bone, Human Pathology 39(1).
- Hallor, K.H.; Staaf, J.; Jonsson, G.; Heidenblad, M.; Steyern, F.V. von; Bauer, H.C.F.; IJszenga, M.; Hogendoorn, P.C.W.; Mandahl, N.; Szuhai, K. & Mertens, F. (2008), Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation, British Journal of Cancer 98(2).
- Ray-Coquard I, Le Cesne A, Whelan JS, Schoffski P, Bui BN, Verweij J, Marreaud S, Van Glabbeke M, Hogendoorn P & Blay JY (2008), A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens, Oncologist 13(4).
- Gelderblom H, Hogendoorn PCW, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AHM & Bovee JVMG (2008), The clinical approach towards chondrosarcoma, Oncologist 13(3).
- Gomes, C.M.F.; Welling, M.; Que, I.; Henriquez, N.V.; Pluijm, G. van der; Romeo, S.; Abrunhosa, A.J.; Botelho, M.F.; Hogendoorn, P.C.W.; Pauwels, E.K.J. & Cleton-Jansen, A.M. (2007), Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using Tc-99m-sestamibi, European Journal of Nuclear Medicine and Molecular Imaging 34(11).
- Heyning, F.H.; Kroon, H.M.J.A.; Hogendoorn, P.C.W.; Taminiau, A.H.M. & Woude, H.J. van der (2007), MR imaging characteristics in primary lymphoma of bone with emphasis on non-aggressive appearance, Skeletal Radiology 36(10).
- Willems SM, Szuhai K, Hartgrink H, Bovee JVMG, De Schepper A & Hogendoorn PCW (2007), CT-guided, COBRA-FISH-assisted diagnosis of well-differentiated liposarcoma (inflammatory subtype) of the retroperitoneum, Histopathology 51(3).
- Lehtonen, H.J.; Makinen, M.J.; Kjuru, M.; Laiho, P.; Herva, R.; Minderhout, I. van; Hogendoorn, P.C.W.; Cornelisse, C.; Devilee, P.; Launonen, V. & Aaltonen, L.A. (2007), Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability, International Journal of Cancer 121(6).
- Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, Radford JA, Van Glabbeke MM, Kirkpatrick A, Hogendoorn PCW & Blay JY (2007), Phase III trial of two Investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study, Journal of Clinical Oncology 25(21).
- Szuhai K, IJszenga M, Knijnenburg J, Dijkstra S, de Schepper A, Tanke HJ & Hogendoorn PCW (2007), Does parosteal liposarcoma differ from other atypical lipomatous tumors/well-differentiated liposarcomas? A molecular cytogenetic study using combined multicolor COBRA-FISH karyotyping and array-based comparative genomic hybridization, Cancer Genetics and Cytogenetics 176(2).
- Romeo S, Oosting J, Rozeman LB, Hameetman L, Taminiau AHM, Cleton-Jansen AM, Bovee JVMG & Hogendoorn PCW (2007), The role of noncartilage-specific molecules in differentiation of cartilaginous tumors - Lessons from chondroblastoma and chondromyxoid fibroma, Cancer 110(2).
- da Costa CET, Egeler RM, Hoogeboorn M, Szuhai K, Forsyth RG, Niesters M, de Krijger RR, Tazi A, Hogendoorn PCW & Annels NE (2007), Differences in telomerase expression by the CD1a(+) cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease, Journal of Pathology 212(2).
- Hameetman L, David G, Yavas A, White SJ, Taminiau AHM, Cleton-Jansen AM, Hogendoorn PCW & Bovee JVMG (2007), Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas, Journal of Pathology 211(4).
- Hameetman, L.; Szuhai, K.; Yavas, A.; Knijnenburg, J.; Duin, M. van; Dekken, H. van; Taminiau, A.H.M.; Cleton-Jansen, A.M.; Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2007), The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions, Journal of the National Cancer Institute 99(5).
- De Schepper AM, Hogendoorn PCW & Bloem JL (2007), Giant cell tumors of the tendon sheath may present radiologically as intrinsic osseous lesions, European Radiology 17(2).
- Grogan, S.P.; Barbero, A.; Diaz-Romero, J.; Cleton-Jansen, A.M.; Soeder, S.; Whiteside, R.; Hogendoorn, P.C.W.; Farhadi, J.; Aigner, T.; Martin, I. & Mainil-Varlet, P. (2007), Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity, Arthritis and Rheumatism 56(2).
- Tolar, J.; Nauta, A.J.; Osborn, M.J.; Mortari, A.P.; McElmurry, R.T.; Bell, S.; Xia, L.L.; Zhou, N.; Riddle, M.; Schroeder, T.M.; Westendorf, J.J.; McIvor, R.S.; Hogendoorn, P.C.W.; Szuhai, K.; Oseth, L.; Hirsch, B.; Yant, S.R.; Kay, M.A.; Peister, A.; Prockop, D.J.; Fibbe, W.E. & Blazar, B.R. (2007), Sarcoma derived from cultured mesenchymal stem cells, Stem Cells 25(2).
- Bezooijen, R.L. van; DeRuiter, M.C.; Vilain, N.; Monteiro, R.M.; Visser, A.; Wee-Pals, L. van der; Munsteren, C.J. van; Hogendoorn, P.C.W.; Aguet, M.; Mummery, C.L.; Papapoulos, S.E.; Dijke, P. ten & Lowik, C.W.G.M. (2007), SOST expression is restricted to the great arteries during embryonic and neonatal cardiovascular development, Developmental Dynamics 236(2).
- Dekker PBD, Kuipers-Dijkshoorn NJ, Baelde HJ, van der Mey AGL, Hogendoorn PCW & Cornelisse CJ (2007), Basic fibroblast growth factor and fibroblastic growth factor receptor-1 may contribute to head and neck paraganglioma development by an autocrine or paracrine mechanism, Human Pathology 38(1).
- Leahy M, Ray-Coquard I, Verweij J, Le Cesne A, Duffaud F, Hogendoorn PCW, Fowst C, de Balincourt C, di Paola ED, van Glabbeke M, Judson I & Blay JY (2007), Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: A phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, European Journal of Cancer 43(2).
- Lewis, I.J.; Nooij, M.A.; Whelan, J.; Sydes, M.R.; Grimer, R.; Hogendoorn, P.C.W.; Memon, M.A.; Weeden, S.; Uscinska, B.M.; Glabbeke, M. van; Kirkpatrick, A.; Hauben, E.I.; Craft, A.W.; Taminiau, A.H.M.; MRC BO06 Collaborators; EORTC 80931 Collaborators & European Osteosarcoma Intergrp (2007), Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup, Journal of the National Cancer Institute 99(2).
- Szuhai K, IJszenga M, Tanke HJ, Taminiau AHM, de Schepper A, van Duinen SG, Rosenberg C & Hogendoorn PCW (2007), Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma, Cancer Genetics and Cytogenetics 172(1).
- Hooge, A.S.K. de; Berghuis, D.; Santos, S.J.; Mooiman, E.; Romeo, S.; Kummer, J.A.; Egeler, R.M.; Tol, M.J.D. van; Melief, C.J.M.; Hogendoorn, P.C.W. & Lankester, A.C. (2007), Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways, Clinical Cancer Research 13(1).
- Rozeman, L.B.; Cleton-Jansen, A.M. & Hogendoorn, P.C.W. (2006), Pathology of primary malignant bone and cartilage tumours, International Orthopaedics 30(6).
- Hyzy MD, Hogendoorn PCW, Bloem JL & De Schepper AM (2006), Chondroid lipoma: findings on radiography and MRI (2006 : 7b), European Radiology 16(10).
- Gomes CMF, van Paassen H, Romeo S, Welling MM, Feltsma RIJ, Abrunhosa AJ, Botelho MF, Hogendoorn PCW, Pauwels E & Cleton-Jansen AM (2006), Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies, Nuclear Medicine and Biology 33(7).
- Dhondt E, Oudenhoven L, Khan S, Kroon HM, Hogendoorn PC, Nieborg A, Bloem JL & De Schepper A (2006), Nora's lesion, a distinct radiological entity?, Skeletal Radiology 35(7).
- Rozeman, L.B.; Szuhai, K.; Schrage, Y.M.; Rosenberg, C.; Tanke, H.J.; Taminiau, A.H.M.; Cleton-Jansen, A.M.; Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2006), Array-comparative genomic hybridization of central chondrosarcoma - Identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations, Cancer 107(2).
- Szuhai K, IJszenga M, Tanke HJ, Rosenberg C & Hogendoorn PCW (2006), Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines, Cancer Genetics and Cytogenetics 166(2).
- Hauben EI, Bielack S, Grimer R, Jundt G, Reichardt P, Sydes M, Taminiau AHM & Hogendoorn PCW (2006), Clinico-histologic parameters of osteosarcoma patients with late relapse, European Journal of Cancer 42(4).
- Willems, S.M.; Debiec-Rychter, M.; Szuhai, K.; Hogendoorn, P.C.W. & Sciot, R. (2006), Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model, Modern Pathology 19(3).
- Oudenhoven LFIJ, Dhondt E, Kahn S, Nieborg A, Kroon HMJ, Hogendoorn PCW, Gielen JL, Bloem JL & De Schepper A (2006), Accuracy of radiography in grading and tissue-specific diagnosis - a study of 200 consecutive bone tumors of the hand, Skeletal Radiology 35(2).
- Romeo S, Eyden B, Prins FA, Briaire-de Bruijn IH, Taminiau AHM & Hogendoorn PCW (2006), TGF-beta 1 drives partial myofibroblastic differentiation in chondromyxoid fibroma of bone, Journal of Pathology 208(1).
- Goettsch, W.G.; Bos, S.D.; Breekveldt-Postma, N.; Casparie, M.; Herings, R.M.C. & Hogendoorn, P.C.W. (2005), Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study, European Journal of Cancer 41(18).
- Nicholls BM, Bredius RGM, Hamdy NAT, Gerritsen EJA, Lankester AC, Hogendoorn PCW, Nesbitt SA, Horton MA & Flanagan AM (2005), Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor, Journal of Bone and Mineral Research 20(12).
- Schaft, D.W.J. van der; Hillen, F.; Pauwels, P.; Kirschmann, D.A.; Castermans, K.; Egbrink, M.G.A.O.; Tran, M.G.B.; Sciot, R.; Hauben, E.; Hogendoorn, P.C.W.; Delattre, O.; Maxwell, P.H.; Hendrix, M.J.C. & Griffioen, A.W. (2005), Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia, Cancer Research 65(24).
- Cleton-Jansen, A.M.; Beerendonk, H.M. van; Baelde, H.J.; Bovee, J.V.G.M.; Karperien, M. & Hogendoorn, P.C.W. (2005), Estrogen signaling is active in cartilaginous tumors: Implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma, Clinical Cancer Research 11(22).
- Rozeman LB, Hameetman L, van Wezel T, Taminiau AHM, Cleton-Jansen AM, Hogendoorn PCW & Bovee JVMG (2005), cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade, Journal of Pathology 207(1).
- Hauben EI, Jundt G, Cleton-Jansen AM, Yavas A, Kroon HM, Van Marck E & Hogendoorn PCW (2005), Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin, Human Pathology 36(9).
- van de Kamp JM, van der Smagt JJ, Bos CFA, van Haeringen A, Hogendoorn PCW & Breuning MH (2005), Bifurcation of the femur with tibial agenesis and additional anomalies, American Journal of Medical Genetics Part A 138A(1).
- Bovee JVMG, Cleton-Jansen AM, Taminiau AHM & Hogendoorn PCW (2005), Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment, Lancet Oncology 6(8).
- Van Glabbeke M, Verweij J, Casali PG, Le Cesne A, Hohenberger P, Ray-Coquard I, Schlemmer M, van Oosterom AT, Goldstein D, Sciot R, Hogendoorn PCW, Brown M, Bertulli R & Judson IR (2005), Initial and late resistance to imatinib in advanced gastrointestinal stromal. tumors are predicted by different prognostic factors: A European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study, Journal of Clinical Oncology 23(24).
- Romeo S, Bovee JVMG, Grogan SP, Taminiau AH, Eilers PHC, Cleton-Jansen AM, Mainil-Varlet P & Hogendoorn PCW (2005), Chondromyxoid fibroma resembles in vitro chondrogenesis, but differs in expression of signalling molecules, Journal of Pathology 206(2).
- Blay, J.Y.; Bonvalot, S.; Casali, P.; Choi, H.; Debiec-Richter, M.; Tos, A.P. dei; Emile, J.F.; Gronchi, A.; Hogendoorn, P.C.W.; Joensuu, H.; Cesne, A. le; Mac Clure, J.; Maurel, J.; Nupponen, N.; Ray-Coquard, I.; Reichardt, P.; Sciot, R.; Stroobants, S.; Glabbeke, M. van; Oosterom, A. van; Demetri, G.D. & GIST Consensus Meeting Panelists (2005), Consensus meeting for the management of gastrointestinal stromal tumors - Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO, Annals of Oncology 16(4).
- Vink, G.R.; White, S.J.; Gabelic, S.; Hogendoorn, P.C.W.; Breuning, M.H. & Bakker, E. (2005), Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations, European Journal of Human Genetics 13(4).
- Hameetman L, Kok P, Eilers PHC, Cleton-Jansen AM, Hogendoorn PCW & Bovee JVMG (2005), The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting, Virchows Archiv 446(4).
- Rozeman, L.B.; Hameetman, L.; Cleton-Jansen, A.M.; Taminiau, A.H.M.; Hogendoorn, P.C. & Bovee, J.V.M.G. (2005), Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas, Journal of Pathology 205(4).
- Costa, C.E.T. da; Annels, N.E.; Faaij, C.M.J.M.; Forsyth, R.G.; Hogendoorn, P.C.W. & Egeler, R.M. (2005), Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis, Journal of Experimental Medicine 201(5).
- van Roggen JFG, van Unnik JAM, Briaire-de Bruijn IH & Hogendoorn PCW (2005), Aggressive angiomyxoma: a clinicopathological and immunohistochemical study of 11 cases with long-term follow-up, Virchows Archiv 446(2).
- Sueters M, Peek AML, Ball LM, Hogendoorn PCW, Scherjon SA, de Keizer RJW & Schalij-Delfos NE (2005), Prenatal detection of orbital rhabdomyosarcoma, Archives of Ophthalmology -New Series- 123(2).
- Nooij MA, Whelan J, Bramwell VHC, Taminiau AT, Cannon S, Hogendoorn PCW, Pringle J, Uscinska BM, Weeden S, Kirkpatrick A, von Glabbeke M & Craft AW (2005), Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study, European Journal of Cancer 41(2).
- Van der Woude HJ, Hazelbag HM, Bloem JL, Taminiau AHM & Hogendoorn PCW (2004), MRI of adamantinoma of long bones in correlation with histopathology, American Journal of Roentgenology 183(6).
- Kornaat PR, Doornbos J, van der Molen AJ, Kloppenburg M, Nelissen RG, Hogendoorn PCW & Bloem JL (2004), Magnetic resonance imaging of knee cartilage using a water selective balanced steady-state free precession sequence, Journal of Magnetic Resonance Imaging 20(5).
- Hazelbag, H.M.; Szuhai, K.; Tanke, H.J.; Rosenberg, C. & Hogendoorn, P.C.W. (2004), Primary synovial sarcoma of the heart: a cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH of a case with a complex karyotype, Modern Pathology 17(11).
- van Rijswijk CSP, Geirnaerdt MJA, Hogendoorn PCW, Taminiau AHM, van Coevorden F, Zwinderman AH, Pope TL & Bloem JL (2004), Soft-tissue tumors: Value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy, Radiology 233(2).
- Verweij J, Casali PG, Zalcberg J, LeCesne A, Reichardt P, Blay JY, Issels R, van Oosterom A, Hogendoorn PCW, Van Glabbeke M, Bertulli R & Judson I (2004), Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial, Lancet 364(9440).
- Lindeman, J.H.N.; Hanemaaijer, R.; Mulder, A.; Dijkstra, S.; Szuhai, K.; Bromme, D.; Verheijen, J.H. & Hogendoorn, P.C.W. (2004), Cathepsin K is the principal protease in giant cell tumor of bone, American Journal of Pathology 165(2).
- Szuhai K, Knijnenburg J, Ijszenga M, Tanke HJ, Baatenburg RJ, de Jong RJB, Dekker PBD, Rosenberg C & Hogendoorn PCW (2004), Multicolor fluorescence in situ hybridization analysis of a synovial sarcoma of the larynx with a t(X;18)(p11.2;q11.2) and trisomy-2 and trisomy-8, Cancer Genetics and Cytogenetics 153(1).
- Hogendoorn PCW, Collin F, Daugaard S, Dei Tos AP, Fisher C, Schneider U & Sciot R (2004), Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment, European Journal of Cancer 40(11).
- Blay JY, Le Cesne A, Verweij J, Scurr M, Seynaeve C, Bonvalot S, Hogendoorn P, Jimeno J, Evrard V, van Glabbeke M & Judson I (2004), A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumours, European Journal of Cancer 40(9).
- Anninga JK, van de Vijver MJ, Cleton-Jansen AM, Kristel PMP, Taminiau AHM, Nooij M, Egeler RM & Hogendoorn PCW (2004), Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas, European Journal of Cancer 40(7).
- Hensen, E.F.; Jordanova, E.S.; Minderhout, I.J.H.M. van; Hogendoorn, P.C.W.; Taschner, P.E.M.; Mey, A.G.L. van der; Devilee, P. & Cornelisse, C.J. (2004), Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families, Oncogene 23(23).
- Schaefer, K.L.; Brachwitz, K.; Wai, D.H.; Braun, Y.; Diallo, R.; Korsching, E.; Eisenacher, M.; Voss, R.; Valen, F. van; Baer, C.; Selle, B.; Spahn, L.; Liao, S.K.; Lee, K.A.W.; Hogendoorn, P.C.W.; Reifenberger, G.; Gabbert, H.E. & Poremba, C. (2004), Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3, Cancer Research 64(10).
- PCW Hogendoorn (2005), Richtlijn Diagnostiek bij wekedelentumoren en behandeling van wekedelensarcomen (herziening) , Nederlands Tijdschrift voor Geneeskunde 149(17).
- van Beerendonk HM, Rozeman LB, Taminiau AH, Sciot R, Bovee JVMG, Cleton-Jansen AM & Hogendoorn PC (2004), Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression, Journal of Pathology 202(3).
- Cleton-Jansen, A.M.; Timmerman, M.C.; Vijver, M.J. van de; Asperen, C.J. van; Kroon, H.M.; Eilers, P.H. & Hogendoorn, P.C. (2004), A distinct phenotype characterizes tumors from a putative genetic trait involving chondrosarcoma and breast cancer occurring in the same patient, Laboratory Investigation 84(2).
- Romeo S, Bovee JVMG, Jadnanansing NAA, Taminiau AHM & Hogendoorn PCW (2004), Expression of cartilage growth plate signalling molecules in chondroblastoma, Journal of Pathology 202(1).
- Rozeman, L.B.; Sangiorgi, L.; Briaire-de Bruijn, I.H.; Mainil-Varlet, P.; Bertoni, F.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2004), Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C, Human Mutation 24(6).
- Hazelbag HM, Laforga JB, Roels HJL & Hogendoorn PCW (2003), Dedifferentiated adamantinoma with revertant mesenchymal phenotype, American Journal of Surgical Pathology 27(12).
- Dekker PBD, Hogendoorn PCW, Kuipers-Dijkshoorn N, Prins FA, van Duinen SG, Taschner PEM, van der Mey AGL & Cornelisse CJ (2003), SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology, Journal of Pathology 201(3).
- Verweij J, van Oosterom A, Blay JY, Judson I, Rodenhuis S, van der Graaf W, Radford J, Le Cesne A, Hogendoorn PCW, di Paola ED, Brown M & Nielsen OS (2003), Imatinib mesylate (STI-571 Glivec (R), Gleevec (TM)) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target: Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study, European Journal of Cancer 39(14).
- Hogendoorn PCW (2003), Pathology of soft tissue sarcomas with emphasis on molecular diagnostic techniques, EJC Supplements 1(6).
- van Rijswijk CSP, Geirnaerdt MJA, Hogendoorn PCW, Peterse JL, van Coevorden F, Taminiau AHM, Tollenaar RAEM, Kroon BBR & Bloem JL (2003), Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results, European Radiology 13(8).
- Hauben, E.I.; Arends, J.; Vandenbroucke, J.P.; Asperen, C.J. van; Marck, E. van & Hogendoorn, P.C.W. (2003), Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma, European Journal of Human Genetics 11(8).
- Egeler RM, Laman JD, Leenen PJM, Annels NE & Hogendoorn PCW (2003), Response to Fadeel and Henter: Langerhans cell histiocytosis: a combination of carcinogenesis and inflammation, Trends in Immunology 24(8).
- Dekker PBD, Kuipers-Dijkshoorn N, Hogendoorn PCW, Van der Mey AGL & Cornelisse CJ (2003), G(2)M arrest, blocked apoptosis, and low growth fraction may explain indolent behavior of head and neck paragangliomas, Human Pathology 34(7).
- Annels, N.E.; Costa, C.E.T. da; Prins, F.A.; Willemze, A.; Hogendoorn, P.C.W. & Egeler, R.M. (2003), Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis, Journal of Experimental Medicine 197(10).
- Laman JD, Leenen PJM, Annels NE, Hogendoorn PCW & Egeler RM (2003), Langerhans-cell histiocytosis 'insight into DC biology', Trends in Immunology 24(4).
- van Dartel M, Cornelissen PWA, Redeker S, Tarkkanen M, Knuutila S, Hogendoorn PCW, Westerveld A, Gomes I, Bras J & Hulsebos TJM (2002), Amplification of 17p11.2 similar to p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma, Cancer Genetics and Cytogenetics 139(2).
- Pauwels P, Debiec-Rychter M, Sciot R, Vlasveld T, den Butter B, Hagemeijer A & Hogendoorn PCW (2002), Clear cell sarcoma of the stomach, Histopathology 41(6).
- Schouten B, Egeler RM, Leenen PJM, Taminiau AHM, van den Broek LJCM & Hogendoorn PCW (2002), Expression of cell cycle-related gene products in Langerhans cell histiocytosis, Journal of Pediatric Hematology/Oncology 24(9).
- Pinto CH, Taminiau AHM, Vanderschueren G, Hogendoorn PCW, Bloem JL & Obermann WR (2002), Perspective. Technical considerations in CT-guided radiofrequency thermal ablation of osteoid osteoma: tricks of the trade., American Journal of Roentgenology 179(6).
- Deijkers RLM, Bloem RM, Hogendoorn PCW, Verlaan JJ, Kroon HM & Taminiau AHM (2002), Hemicortical allograft reconstruction after resection of low-grade malignant bone tumours, Journal of Bone and Joint Surgery, British Volume 84B(7).
- Hauben EI, Weeden S, Pringle J, Van Marck EA & Hogendoorn PCW (2002), Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup, European Journal of Cancer 38(9).
- Rijswijk, C.S.P. van; Kunz, P.; Hogendoorn, P.C.W.; Taminiau, A.H.M.; Doornbos, J. & Bloem, J.L. (2002), Diffusion-weighted MRI in the characterization of soft-tissue tumors, Journal of Magnetic Resonance Imaging 15(3).
- Svancarova L, Blay JY, Judson IR, van Hoesel QGCM, van Oosterom AT, le Cesne A, Keizer HJ, Hermans C, van Glabbeke M, Verweij J, Hogendoorn PCW & Nielsen OS (2002), Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group, European Journal of Cancer 38(4).
- Bovee, J.V.M.G.; Sakkers, R.J.B.; Geirnaerdt, M.J.A.; Taminiau, A.H.M. & Hogendoorn, P.C.W. (2002), Intermediate grade osteosarcoma and chondrosarcoma arising in an osteochondroma. A case report of a patient with hereditary multiple exostoses, Journal of Clinical Pathology 55(3).
- Janssen, J.P.; Egmont-Petersen, M.; Hendriks, E.A.; Reinders, M.J.T.; Geest, R.J. van der; Hogendoorn, P.C.W. & Reiber, J.H.C. (2002), Scale-invariant segmentation of dynamic contrast-enhanced perfusion MR images with inherent scale selection, Journal of Visualization and Computer Animation 13(1).
- Hazelbag HM & Hogendoorn PC (2001), Adamantinoma of long bones: a clinicopathological review and its relationship with osteofibrous dysplasia, Annales de Pathologie 21(6).
- Bovee JVMG, Sciot R, Cin PD, Debiec-Rychter M, van Zelderen-Bhola SL, Cornelisse CJ & Hogendoorn PCW (2001), Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: A cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes, Diagnostic Molecular Pathology 10(4).
- Baelde, H.J.; Cleton-Jansen, A.M.; Beerendonk, H. van; Namba, M.; Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2001), High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma, Journal of Clinical Pathology 54(10).
- Hauben, E.; Broek, L.C.J.M. van den; Marck, E. van & Hogendoorn, P.C.W. (2001), Adamantinoma-like Ewing's sarcoma and Ewing's-like adamantinoma. The t(11;22), t(21;22) status, Journal of Pathology 195(2).
- Nelissen, R.G.H.H. & Hogendoorn, P.C.W. (2001), Retain or sacrifice the posterior cruciate ligament in total knee arthroplasty? A histopathological study of the cruciate ligament in osteoarthritic and rheumatoid disease, Journal of Clinical Pathology 54(5).
- Langezaal, S.M.; Roggen, J.F.G. van; Cleton-Jansen, A.M.; Baelde, J.J. & Hogendoorn, P.C.W. (2001), Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts), British Journal of Cancer 84(4).
- Roggen, J.F.G. van; Velthuysen, M.L.F. van & Hogendoorn, P.C.W. (2001), The histopathological differential diagnosis of gastrointestinal stromal tumours, Journal of Clinical Pathology 54(2).
- Ronday, H.K.; Laan, W.H. van der; Tak, P.P.; Roos, J.A.D.M. de; Bank, R.A.; TeKoppele, J.M.; Froelich, C.J.; Hack, C.E.; Hogendoorn, P.C.W.; Breedveld, F.C. & Verheijen, J.H. (2001), Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis, Rheumatology 40(1).
- Rijswijk, C.S.P. van; Lieng, J.G.S.T.A.; Kroon, H.M. & Hogendoorn, P.C.W. (2001), Retroperitoneal extraskeletal osteosarcoma, Journal of Clinical Pathology 54(1).
- van Rijswijk CSP, Hogendoorn PCW, Taminiau AHM & Bloem JL (2001), Synovial sarcoma: dynamic contrast-enhanced MR imaging features, Skeletal Radiology 30(1).
- Bovee, J.V.M.G.; Broek, L.J.C.M. van den; Cleton-Jansen, A.M. & Hogendoorn, P.C.W. (2000), Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma, Laboratory Investigation 80(12).
- Plusje LGJM, Bastiaens M, Chang A & Hogendoorn PCW (2000), Infantile-type digital fibromatosis tumour in an adult, British Journal of Dermatology 143(5).
- Bovee, J.V.M.G.; Royen, M. van; Bardoel, A.F.J.; Rosenberg, C.; Cornelisse, C.J.; Cleton-Jansen, A.M. & Hogendoorn, P.C.W. (2000), Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma, American Journal of Pathology 157(5).
- Bovee JVMG, van Roggen JFG, Cleton-Jansen AM, Taminiau AHM, van der Woude HJ & Hogendoorn PCW (2000), Malignant progression in multiple enchondromatosis (Ollier's disease): An autopsy-based molecular genetic study, Human Pathology 31(10).
- Egmont-Petersen M, Hogendoorn PCW, van der Geest RJ, Vrooman HA, van der Woude HJ, Janssen JP, Bloem JL & Reiber JHC (2000), Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing's sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling.
- Beuckeleer, L.H. de; Schepper, A.M. de; Vandevenne, J.E.; Bloem, J.L.; Davies, A.M.; Oudkerk, M.; Hauben, E.; Marck, E. van; Somville, J.; Vanel, D.; Steinbach, L.S.; Guinebretiere, J.M.; Hogendoorn, P.C.W.; Mooi, W.J.; Verstraete, K.; Zaloudek, C. & Jones, H. (2000), MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MRI-pathology study of 21 cases and literature review, Skeletal Radiology 29(4).
- Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2000), Re. Review Article entitled 'The neoplastic pathogenesis of solitary and multiple osteochondromas'.
- Geirnaerdt MJA, Hogendoorn PCW, Bloem JL, Taminiau AHM & van der Woude HJ (2000), Cartilaginous tumors: Fast contrast-enhanced MR imaging.
- van Roggen JF, Bovee JVMG, van der Woude HJ & Hogendoorn PCW (2000), An update of diagnostic strategies using molecular genetic and magnetic resonance imaging techniques for musculoskeletal tumors.
- Bloem JL, van der Woude HJ, Geirnaerdt MJA, Taminiau AHM, Hogendoorn PCW & van Rijswijk CSP (2000), Bone tumors.
- Member Advisory Board
- Adjunct Professor in Pathology
- Chairman of Supervisory Board
- Voorzitter (ex officio)
- CSO Top Team
- Lid Bestuur (ex officio)
- Voorzitter Raad van Commissarissen (ex officio)
- Lid Raad van Toezicht
- Lid Programmaraad
- Aandeelhouder (ex officio)
- Chair of the policy group in Biomedicine
- Lid Raad van Toezicht
- Lid Kenniscoalitie
- Voorzitter
- Lid bestuur (ex officio)
- Lid
- Lid bestuur (ex officio)
- Lid Raad van Toezicht
- Visiting Professor in Sarcoma Pathology
- Visiting Professor of Pathology
- Lid Raad van Toezicht